var title_f12_18_12576="GlideScope Cobalt video laryngoscope";
var content_f12_18_12576=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    GlideScope Cobalt video laryngoscope",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 388px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The GlideScope&reg; Cobalt laryngoscope comes with a handle and disposable blade that is suitable for use in patients from neonates to adults.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Verathon Medical. Copyright &copy; 2011. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12576=[""].join("\n");
var outline_f12_18_12576=null;
var title_f12_18_12577="Blastomycosis chest CT";
var content_f12_18_12577=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F83713&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F83713&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 491px\">",
"   <div class=\"ttl\">",
"    Blastomycosis on chest CT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 471px; height: 162px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blastomycosis in a 69-year-old woman.",
"    <br>",
"     (A) High-resolution (1 mm collimation) computed tomography (CT) image at the level of the aortic arch shows small centrilobular nodules (arrows) in the left upper lobe.",
"     <br>",
"      (B) CT scan obtained at the level of the basal trunk demonstrates areas of consolidation in the left lower lobe. Also note tree-in-bud opacities (arrows) in both lower lobes.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Imaging of Pulmonary Infections, M&uuml;ller NL, Franquet T, Lee KS (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"      </div>",
"      <div class=\"contractual\">",
"       <br/>",
"       <a href=\"file://www.lww.com\">",
"        file://www.lww.com",
"       </a>",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12577=[""].join("\n");
var outline_f12_18_12577=null;
var title_f12_18_12578="Lateral CXR showing pericardial calcium";
var content_f12_18_12578=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64005&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64005&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lateral chest radiograph (CXR) showing pericardial calcium",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 280px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This lateral chest radiograph demonstrates coarse calcification involving the entire pericardium (arrows) in this patient who has a history of prior hemopericardium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal lateral chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 368px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven Weinberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12578=[""].join("\n");
var outline_f12_18_12578=null;
var title_f12_18_12579="Patient information: Preserving fertility after cancer treatment in women (The Basics)";
var content_f12_18_12579=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83957\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"         Female reproductive anatomy",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/4/36930\">",
"         Patient information: Absent or irregular periods (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/19/2357\">",
"         Patient information: Breast cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/32/28163\">",
"         Patient information: Cervical cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/41/3731\">",
"         Patient information: Hysterectomy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/16/11523\">",
"         Patient information: Infertility in women (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/1/11283\">",
"         Patient information: Ovarian cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/32/40450\">",
"         Patient information: Radiation therapy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/12/23747\">",
"         Patient information: Uterine cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/40/33411\">",
"         Patient information: Vaginal cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?6/16/6405\">",
"         Patient information: Abdominal hysterectomy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?8/12/8388\">",
"         Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/46/30436\">",
"         Patient information: Fertility preservation in women with early stage cervical cancer (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/34/41507\">",
"         Patient information: First-line medical treatment of epithelial ovarian cancer (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Preserving fertility after cancer treatment in women (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/preserving-fertility-after-cancer-treatment-in-women-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H199021068\">",
"      <span class=\"h1\">",
"       What is fertility?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Fertility is the term doctors use to describe a woman&rsquo;s ability to get pregnant. After some types of cancer treatment, women can have trouble getting pregnant. &ldquo;Preserving fertility after cancer treatment&rdquo; involves doing things before or during cancer treatment to raise a woman&rsquo;s chances of getting pregnant later on.",
"     </p>",
"     <p>",
"      <strong>",
"       Which cancer treatments can cause fertility problems?",
"      </strong>",
"      &ndash; Cancer treatments that can cause fertility problems include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Chemotherapy &ndash; Chemotherapy is the term doctors use to describe a group of medicines that kill cancer cells.",
"       </li>",
"       <li>",
"        Radiation therapy &ndash; Radiation involves getting high doses of X-rays.",
"       </li>",
"       <li>",
"        Surgery &ndash; If a woman&rsquo;s ovaries (female sex organs) are removed, she can&rsquo;t get pregnant (",
"        <a class=\"graphic graphic_figure graphicRef80271 \" href=\"UTD.htm?14/52/15171\">",
"         figure 1",
"        </a>",
"        ). If a woman&rsquo;s uterus is removed, she can&rsquo;t carry a pregnancy.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Chemotherapy and radiation can damage or destroy eggs in the ovaries. As a result, women might stop having periods or have irregular periods. Also, radiation can damage the uterus, which can make it hard to carry a pregnancy.",
"     </p>",
"     <p>",
"      Not everyone who gets chemotherapy or radiation will have fertility problems. With chemotherapy, it depends on the medicine and dose a person gets. With radiation, it depends on the dose and part of the body treated.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H199021106\">",
"      <span class=\"h1\">",
"       What should I do if I want to get pregnant someday?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should let your doctor know",
"      <strong>",
"       BEFORE",
"      </strong>",
"      you start your cancer treatment. In some cases, treatment that has a lower chance of affecting future fertility might be available.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H199021121\">",
"      <span class=\"h1\">",
"       Are there other ways to preserve fertility?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Different things that can be done to help women preserve their fertility include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Embryo banking &ndash; This involves collecting eggs before you start cancer treatment. The doctor fertilizes the eggs with sperm in a lab to make embryos. An embryo is a group of cells that grow after a woman&rsquo;s egg and a man&rsquo;s sperm join together. The embryos can then be frozen and stored until they are used later on.",
"       </li>",
"       <li>",
"        Shielding the ovaries or uterus during radiation treatment &ndash; This involves wearing a special shield on the outside of your body during radiation treatment. The shield covers and protects your organs, so they aren&rsquo;t damaged by the radiation.",
"       </li>",
"       <li>",
"        Moving your ovaries &ndash; If your ovaries are in the path of the radiation, your doctor can move them slightly to keep them from getting damaged.",
"       </li>",
"       <li>",
"        Taking medicines to keep your ovaries from working as well during your cancer treatment",
"       </li>",
"       <li>",
"        Freezing and storing eggs (that are not fertilized) or tissue from your ovaries",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H199021136\">",
"      <span class=\"h1\">",
"       How do I decide which option is right for me?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The best way to preserve your fertility depends on your cancer, treatment, age, and individual situation. Talk with your doctor about your different choices. To make your decision, you might want to think about:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        The benefits and downsides of the choices",
"       </li>",
"       <li>",
"        How long they take &ndash; For example, embryo banking takes a few weeks. This could delay the start of your cancer treatment.",
"       </li>",
"       <li>",
"        How well your doctor thinks they will work",
"       </li>",
"       <li>",
"        How much they cost &ndash; For example, it costs money to collect, freeze, and store embryos. Health insurance sometimes pays for these things.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H199021153\">",
"      <span class=\"h1\">",
"       What if I still can&rsquo;t get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you still can&rsquo;t get pregnant after cancer treatment, you have other choices:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        You and your partner can try to have a baby using a donated egg.",
"       </li>",
"       <li>",
"        You can have another woman (called a &ldquo;surrogate&rdquo;) carry a pregnancy for you.",
"       </li>",
"       <li>",
"        You might choose to adopt.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Couples can have a tough time making these decisions. You might find it helpful to talk to a counselor or go to a support group for people who are facing the same issues.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H199021170\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/1/11283?source=see_link\">",
"       Patient information: Ovarian cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23747?source=see_link\">",
"       Patient information: Uterine cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/19/2357?source=see_link\">",
"       Patient information: Breast cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/32/28163?source=see_link\">",
"       Patient information: Cervical cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/41/3731?source=see_link\">",
"       Patient information: Hysterectomy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/4/36930?source=see_link\">",
"       Patient information: Absent or irregular periods (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/16/11523?source=see_link\">",
"       Patient information: Infertility in women (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/32/40450?source=see_link\">",
"       Patient information: Radiation therapy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/40/33411?source=see_link\">",
"       Patient information: Vaginal cancer (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/16/6405?source=see_link\">",
"       Patient information: Abdominal hysterectomy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/12/8388?source=see_link\">",
"       Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/34/41507?source=see_link\">",
"       Patient information: First-line medical treatment of epithelial ovarian cancer (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/46/30436?source=see_link\">",
"       Patient information: Fertility preservation in women with early stage cervical cancer (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?12/18/12579?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83957 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-66B715A8D5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12579=[""].join("\n");
var outline_f12_18_12579=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199021068\">",
"      What is fertility?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199021106\">",
"      What should I do if I want to get pregnant someday?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199021121\">",
"      Are there other ways to preserve fertility?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199021136\">",
"      How do I decide which option is right for me?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199021153\">",
"      What if I still can&rsquo;t get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199021170\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83957\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"      Female reproductive anatomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/16/6405?source=related_link\">",
"      Patient information: Abdominal hysterectomy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/4/36930?source=related_link\">",
"      Patient information: Absent or irregular periods (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/19/2357?source=related_link\">",
"      Patient information: Breast cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/32/28163?source=related_link\">",
"      Patient information: Cervical cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/12/8388?source=related_link\">",
"      Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/46/30436?source=related_link\">",
"      Patient information: Fertility preservation in women with early stage cervical cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/34/41507?source=related_link\">",
"      Patient information: First-line medical treatment of epithelial ovarian cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/41/3731?source=related_link\">",
"      Patient information: Hysterectomy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/16/11523?source=related_link\">",
"      Patient information: Infertility in women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/1/11283?source=related_link\">",
"      Patient information: Ovarian cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/32/40450?source=related_link\">",
"      Patient information: Radiation therapy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/12/23747?source=related_link\">",
"      Patient information: Uterine cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/40/33411?source=related_link\">",
"      Patient information: Vaginal cancer (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_18_12580="Radiation field stage II HL";
var content_f12_18_12580=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F77839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F77839&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Involved-field radiation for a patient with stage II Hodgkin lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient with stage II Hodgkin lymphoma extensively involving the right neck and with a solitary node in the left neck. The gross tumor volume (PET + disease) is displayed in red; the&nbsp;clinical treated volume&nbsp;(involved lymph node regions) is displayed in green.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Yahalom J, Hoppe RT, Mauch PM. Principles and Techniques of Radiation Therapy for Hodgkin Lymphoma. In: Hodgkin Lymphoma, 2nd ed, Hoppe RT, Mauch PT, Armitage JO, et al. (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12580=[""].join("\n");
var outline_f12_18_12580=null;
var title_f12_18_12581="Sipuleucel-T: Drug information";
var content_f12_18_12581=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"19\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sipuleucel-T: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?12/4/12356?source=see_link\">",
"    see \"Sipuleucel-T: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F10170443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Provenge&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F10170597\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Cellular Immunotherapy, Autologous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F10181491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Premedicate with oral acetaminophen 650 mg and an antihistamine (eg, diphenhydramine 50 mg) ~30 minutes prior to infusion. For autologous use only. Do not infuse until confirmation of product release has been received from the company.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prostate cancer, metastatic:",
"     </b>",
"     I.V.: Each dose contains &ge;50 million autologous CD54+ cells (obtained through leukapheresis) activated with PAP-GM-CSF; administer doses at ~2 week intervals for a total of 3 doses (Kantoff, 2010)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F10181492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F10181493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acute infusion reaction: Interrupt or slow infusion rate (depending on the severity of infusion reaction); may require acetaminophen, I.V. H",
"     <sub>",
"      1",
"     </sub>",
"     and/or H",
"     <sub>",
"      2",
"     </sub>",
"     antagonists, or low-dose meperidine to manage acute symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F10181496\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed in LR [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Provenge&reg;: &ge;50 million autologous CD54",
"     <sup>",
"      +",
"     </sup>",
"     cells activated with PAP-GM-CSF (250 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F10181395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11238293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients may receive Sipuleucel-T at a participating site. Physicians must go through an inservice and register to prescribe the treatment; patients must also complete an enrollment form. Information on registration and enrollment is available at 1-877-336-3736.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10181494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For autologous use only; the identity of the patient must be matched to the patient identifiers on the infusion bag and on the &ldquo;Cell Product Disposition Form&rdquo; prior to infusion. Do not infuse until confirmation of product release has been received from the company. Prior to infusion, inspect bag for signs of leaks (do not administer if leaking). Gently mix to resuspend contents; inspect for clumps or clotting; small clumps should disperse with the gentle mixing; do not administer if clumps remain. A cell filter should",
"     <b>",
"      NOT",
"     </b>",
"     be used for administration. If product is expired, do NOT infuse. For I.V. infusion only.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Infuse over ~60 minutes; infuse the entire contents of the bag. If infusion is interrupted, do not resume if bag is retained at room temperature for &gt;3 hours. Observe patient for at least 30 minutes after infusion.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10170508\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of metastatic hormone-refractory prostate cancer in patients who are asymptomatic or minimally symptomatic",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F10181394\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       For autologous use only; patient identity must be matched to the patient identifiers on the infusion bag and on the &ldquo;Cell Product Disposition Form&rdquo; prior to infusion. Healthcare providers should apply universal precautions when handling both the initial leukapheresis product and the activated product.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F10181402\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Initial infusion-related events usually present within the first 24 hours after administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Chills (53%), fatigue (41%), fever (31%), headache (18%), dizziness (12%), pain (12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea (22%), vomiting (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hematologic: Anemia (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Back pain (30%), myalgia (12%), weakness (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Acute infusion reaction (71%; grade 3: 4%), citrate toxicity (15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Hypertension (8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Stroke (hemorrhagic or ischemic: 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Rash (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Muscle spasm (8%), neck pain (6%), tremor (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Renal: Hematuria (8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Dyspnea (9%), cough (6%), upper respiratory tract infection (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Flu-like syndrome (10%), diaphoresis (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Eosinophilia, groin pain, incontinence, myasthenia gravis, myositis, nocturia, obstructive voiding symptoms, rhabdomyolysis, tumor flare, urinary urgency",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10181577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;margin-top:0em;display:inline\">",
"     There are no contraindications listed within the FDA-approved manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10181397\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Infusion reaction: Acute infusion reactions may occur within 1 day of infusion and are usually mild or moderate for most patients; the incidence of severe reaction may be higher with the second infusion, while the third infusion is associated with a decrease in the incidence of severe reactions. Premedication with oral acetaminophen and diphenhydramine is recommended. Depending on the severity of infusion reaction, interrupt or slow infusion rate; in clinical trials, acetaminophen, I.V. H",
"     <sub>",
"      1",
"     </sub>",
"     and/or H",
"     <sub>",
"      2",
"     </sub>",
"     antagonists, and low-dose meperidine were used to manage acute symptoms. Symptoms of acute infusion reaction may include chills, fever, bronchospasm, dyspnea, hypoxia, hypertension, tachycardia, joint or muscle aches, nausea, vomiting, fatigue, headache, and weakness; fever and chills usually resolved within 2 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Cardiovascular disease: Closely monitor during infusion in patients with cardiac conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Pulmonary disease: Closely monitor during infusion in patients with pulmonary conditions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Androgen deprivation therapy: In clinical trials, patients who had androgen deprivation therapy without prior bilateral orchiectomy were continued on gonadal suppression with a luteinizing hormone-releasing hormone (LHRH) agonist (Higano, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Chemotherapy: Concurrent use with chemotherapy has not been studied.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Immunosuppressive therapy: Concurrent use with immunosuppressives (eg, corticosteroids) has not been studied; may alter the efficacy and/or safety of sipuleucel-T.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use: For autologous use only. Patient identity must be matched to the patient identifiers on the infusion bag and on the Cell Product Disposition Form (provided by manufacturer) prior to infusion. Confirmation of product release must be received from the manufacturer prior to infusion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Handling precautions: Apply universal precautions for product handling. Sipuleucel-T is not routinely tested for transmissible infectious diseases; patient specific leukapheresis collection and activated product may have a risk for infectious disease transmission.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Sterility testing: Preliminary sterility testing is done based on a 2-day incubation period. Final (7-day incubation) testing is not available until after administration; physicians will be notified if 7-day sterility tests are positive for microbial contamination.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Treatment delays: If unable to receive a scheduled reinfusion, an additional leukapheresis procedure may be required; advise patients of this possibility before treatment initiation.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F10191787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May diminish the therapeutic effect of Sipuleucel-T.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cytarabine (Liposomal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10181396\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Not indicated for use in women.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F10181576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not indicated for use in women.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F15383294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for infusion reaction for at least 30 minutes after infusion",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10181488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Autologous cellular immunotherapy which stimulates an immune response against an antigen (PAP) expressed in most prostate cancer tissues. Peripheral blood is collected (~3 days prior to infusion) from the patient via leukapheresis, from which peripheral blood mononuclear cells (PBMCs) are isolated. Antigen presenting cell (APC) precursors, consisting of CD54-positive cells that include dendritic cells, are isolated from the PBMCs. The APCs are then activated (",
"     <i>",
"      in vitro",
"     </i>",
"     ) with a recombinant human fusion protein, PAP-GM-CSF (also termed PA2024), composed of an antigen specific for prostate cancer, prostatic acid phosphatase (PAP) linked to granulocyte-macrophage colony-stimulating factor (GM-CSF) and cultured for ~40 hours. The final product, sipuleucel-T, is reinfused into the patient,  inducing T-cell immunity to tumors that express PAP.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Beer TM, Bernstein GT, Corman JM, et al, &ldquo;Randomized Trial of Autologous Cellular Immunotherapy With Sipuleucel-T In Androgen-Dependent Prostate Cancer,&rdquo;",
"      <i>",
"       Clin Cancer Res",
"      </i>",
"      , 2011, 17(13):4558-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/18/12581/abstract-text/21558406/pubmed\" id=\"21558406\" target=\"_blank\">",
"        21558406",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Burch PA, Breen JK, Bruckner JC, et al, &ldquo;Priming Tissue-Specific Cellular Immunity in a Phase I Trial of Autologous Dendritic Cells for Prostate Cancer,&rdquo;",
"      <i>",
"       Clin Cancer Res",
"      </i>",
"      , 2000, 6(6):2175-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/18/12581/abstract-text/10873066/pubmed\" id=\"10873066\" target=\"_blank\">",
"        10873066",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Burch PA, Croghan GA, Gastineau DA, et al, &ldquo;Immunotherapy (APC8015, Provenge&reg;) Targeting Prostatic Acid Phosphatase Can Induce Durable Remission of Metastatic Androgen-Independent Prostate Cancer: A Phase 2 Trial,&rdquo;",
"      <i>",
"       Prostate",
"      </i>",
"      , 2004, 60(3):197-204.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/18/12581/abstract-text/15176049/pubmed\" id=\"15176049\" target=\"_blank\">",
"        15176049",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Higano CS, Schellhammer PF, Small EJ, et al, &ldquo;Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate Cancer,&rdquo;",
"      <i>",
"       Cancer",
"      </i>",
"      , 2009, 115(16):3670-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/18/12581/abstract-text/19536890/pubmed\" id=\"19536890\" target=\"_blank\">",
"        19536890",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kantoff PW, Higano CS, Shore ND, et al, &ldquo;Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer,&rdquo;",
"      <i>",
"       N Engl J Med,",
"      </i>",
"      2010, 363(5):411-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/18/12581/abstract-text/20818862/pubmed\" id=\"20818862\" target=\"_blank\">",
"        20818862",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Patel PH and Kockler DR, &ldquo;Sipuleucel-T: A Vaccine for Metastatic, Asymptomatic, Androgen-Independent Prostate Cancer,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2008, 42(1):91-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/18/12581/abstract-text/18094343/pubmed\" id=\"18094343\" target=\"_blank\">",
"        18094343",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Small EJ, Fratesi P, Reese DM, et al, &ldquo;Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells,&ldquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2000, 18(23):3894-903.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/18/12581/abstract-text/11099318/pubmed\" id=\"11099318\" target=\"_blank\">",
"        11099318",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Small EJ, Schellhammer PF, Higano CS, et al, &ldquo;Placebo-Controlled Phase III Trial of Immunologic Therapy With Sipuleucel-T (APC8015) in Patients With Metastatic, Asymptomatic Hormone Refractory Prostate Cancer,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2006, 24(19):3089-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/18/12581/abstract-text/16809734/pubmed\" id=\"16809734\" target=\"_blank\">",
"        16809734",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9916 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-08F90C6EF9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12581=[""].join("\n");
var outline_f12_18_12581=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10170443\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10170597\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181491\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181492\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181493\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181496\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181395\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11238293\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181494\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10170508\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181394\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181402\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181577\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181397\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300046\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10191787\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181396\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181576\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15383294\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10181488\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9916\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9916|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?12/4/12356?source=related_link\">",
"      Sipuleucel-T: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_18_12582="Inflamed seborrheic keratosis";
var content_f12_18_12582=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Inflamed seborrheic keratosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This erythematous, scaly papule is an inflamed seborrheic keratosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12582=[""].join("\n");
var outline_f12_18_12582=null;
var title_f12_18_12583="Chondro high radiographs";
var content_f12_18_12583=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F65818&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F65818&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Radiological presentation of a high-grade pelvic chondrosarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 516px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Axial T1-weighted magnetic resonance image of high-grade chondrosarcoma arising from the pelvis with cortex destruction and a large soft tissue component. B) Axial T1-weighted magnetic resonance image with fat suppression after IV contrast injection shows areas of solid peripheral enhancement. C) Computed tomography image demonstrates the bone destruction of the right os ilium and os sacrum with a large soft tissue mass with only peripheral mineralization.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gelderblom H, Hogendoorn PCW, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist 2008; 13:320. Copyright &copy;2008 AlphaMed Press.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.TheOncologist.com\">",
"      file://www.TheOncologist.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12583=[""].join("\n");
var outline_f12_18_12583=null;
var title_f12_18_12584="Cystinosis";
var content_f12_18_12584=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cystinosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/18/12584/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/18/12584/contributors\">",
"     Patrick Niaudet, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/18/12584/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/18/12584/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/18/12584/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/18/12584/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/18/12584/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystinosis is a metabolic disease characterized by an accumulation of cystine in different organs and tissues, leading to potentially severe organ dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Three forms of cystinosis have been described: the infantile (nephropathic) form, the intermediate (adolescent, late-onset) form; and the adult (benign) form. Nephropathic cystinosis, which is by far the most common, has been estimated to affect one of every 100,000 to 200,000 children, with an incidence of nearly 6 per 100,000 in Newfoundland, Canada [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystine is derived from protein degradation within the lysosomes of cells. Free cystine is normally transported through the lysosomal membrane to the cytosol where it is reutilized after its transformation to cysteine. In cystinosis, cystine accumulates inside the lysosomes because of a defect in the transport system [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/6-10\">",
"     6-10",
"    </a>",
"    ]. Cystine is poorly soluble and forms crystals as its concentration increases.",
"   </p>",
"   <p>",
"    It is not clear how cystine accumulation results in renal tubular cell dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/2\">",
"     2",
"    </a>",
"    ]. A proposed mechanism is cysteinylation of protein kinase delta by accumulated cystine results increased apoptosis of the cystine-laden renal proximal tubular cell leading to tubular dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/11\">",
"     11",
"    </a>",
"    ]. It has also been shown that cystine accumulation in proximal tubular cells in vitro is associated with ATP depletion and inhibition of Na",
"    <sup>",
"     +",
"    </sup>",
"    dependent transporters [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Inhibition of adenylate cyclase activity by cystine in rat brain is prevented by",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/14\">",
"     14",
"    </a>",
"    ]. In addition, cellular cystine accumulation may inhibit pyruvate kinase and creatine kinase activity in rat brain or pig retina [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Cystine depletes the glutathione cell pool, thereby favoring oxidative stress and apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystinosis is transmitted as an autosomal recessive trait. Multiple observations indicate that the same gene is involved in all forms of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/20\">",
"     20",
"    </a>",
"    ]. Both the infantile and adolescent forms can occur in a given family. In addition, complementation studies using fibroblasts from patients' different types of cystinosis have shown the absence of correction of the metabolic defect [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/21\">",
"     21",
"    </a>",
"    ]. It therefore appears that there is no genetic heterogeneity and that the differences in the clinical manifestations result from mutations occurring in a single gene (allelic mutation).",
"   </p>",
"   <p>",
"    The gene for nephropathic cystinosis has been mapped to chromosome 17p13 and identified [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/22\">",
"     22",
"    </a>",
"    ]. The gene, CTNS, consists of 12 exons and encodes for a 367 amino acid lysosomal membrane protein, named cystinosin [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. It appears to be a novel hydrogen ion driven transporter that is responsible for exporting cystine from lysosomes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A large number of mutations have been described in patients with cystinosis, with the clinical phenotype segregating with specific defects [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/2,26-28\">",
"     2,26-28",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Infantile form",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large deletions, as well as other mutations that would result in missense or in-frame deletions, are associated with infantile cystinosis, the most severe phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/27\">",
"     27",
"    </a>",
"    ]. Among those with such defects in both alleles, these abnormalities may result in the loss of adequate protein function, including no protein expression with some mutations. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Infantile cystinosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A 65 kb deletion is the most frequent mutation found in the homozygous state, being observed in nearly one-third of patients with cystinosis. This deletion is present in either the homozygous or the heterozygous state in approximately 75 percent of patients of European origin [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/29\">",
"     29",
"    </a>",
"    ], thus allowing a rapid PCR-based diagnostic test for this disease. By comparison, a 9.5 to 16 kb deletion has only been infrequently observed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Intermediate form",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermediate cystinosis is more indolent than the other forms of cystinosis (see below). This appears to be due to the inheritance of a mutation known to cause infantile disease in one allele (as above) and a relatively less clinically severe mutation in the other, or the inheritance of a relatively less severe mutation in both alleles [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/27,30\">",
"     27,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Adult cystinosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult or benign (or ocular nonnephropathic) cystinosis is characterized by the presence of corneal crystals and photophobia and less often renal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/31\">",
"     31",
"    </a>",
"    ], and has been associated with additional mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/26,28\">",
"     26,28",
"    </a>",
"    ]. Similar to intermediate cystinosis, this form may be due to the inheritance of different abnormal alleles, including the presence of a severe plus a mild mutation, the latter of which does not adversely affect kidney function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INFANTILE CYSTINOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although cystinosis is characterized by both renal and extrarenal symptoms, children appear normal at birth [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/1,32\">",
"     1,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Renal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first clinical signs of infantile cystinosis appear between three and six months of age; they are largely due to impaired proximal tubular reabsorptive capacity, leading to the varied manifestations of the de Toni-Debr&eacute;-Fanconi syndrome (glycosuria, metabolic acidosis, phosphaturia, and aminoaciduria). Sodium wasting and resistance to antidiuretic hormone (nephrogenic diabetes insipidus) can result in polyuria (reaching 2 to 3",
"    <span class=\"nowrap\">",
"     L/day),",
"    </span>",
"    polydipsia, poor weight gain, vomiting, constipation, weakness, unexplained fever, and acute dehydration episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/33\">",
"     33",
"    </a>",
"    ]. Growth retardation and rickets (manifested by swelling of the wrists, frontal bossing, and genu valgum) are often noted at presentation due in part to phosphate wasting and hypophosphatemia.",
"   </p>",
"   <p>",
"    Other common abnormalities include glucosuria, tubular proteinuria (including generalized amino aciduria), proximal renal tubular acidosis (manifested by a normal anion gap [hyperchloremic] metabolic acidosis), hypokalemia, and hypouricemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/34\">",
"     34",
"    </a>",
"    ]. The tubular losses gradually become less prominent after six years of age due to a progressive decline in the glomerular filtration rate. End-stage renal failure typically occurs before age 10.",
"   </p>",
"   <p>",
"    Histological examination of cystinotic kidneys shows nonspecific tubular and glomerular lesions. The proximal and distal tubules are dilated or atrophic and vacuoles may be seen in the tubular cells. Interstitial fibrosis and glomerulosclerosis are seen in advanced disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Extrarenal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;On general inspection, many affected children have blond hair and a large abdomen. Growth retardation is a major feature of cystinotic patients, often accompanied by a delay in bone age when compared to chronologic age. The mean adult height is only 54 inches (136.5 cm) in males and 49 inches (124 cm) in females. Growth curves have improved in recent years due to early therapy with fluid and electrolyte supplements,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/27/17848?source=see_link\">",
"     indomethacin",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    . Puberty is typically delayed.",
"   </p>",
"   <p>",
"    The extrarenal symptoms are due to the intracellular accumulation of cystine in different tissues and organs [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Eyes &mdash; The eyes are involved early in the course of the disease, as cystine deposits in the cornea and the conjunctiva can be seen on slit-lamp examination. These deposits are responsible for photophobia, watering, and blepharospasm. Irregular and peripheral depigmentation of the retina is also an early finding. Visual impairment may occur later, in children older than 10 years [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]. Hemorrhagic retinopathy may also be a complication of this disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Liver &mdash; Hepatomegaly, resulting from enlarged Kupffer cells with cystine crystals, occurs in 40 percent of patients and may lead to portal hypertension. Splenomegaly, due to enlarged cells in the red pulp, can also be seen.",
"     </li>",
"     <li>",
"      Thyroid &mdash; Hypothyroidism is also common in older children [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/1\">",
"       1",
"      </a>",
"      ]. It can be detected by the demonstration of high plasma TSH levels, which occur before the thyroxine concentration begins to fall [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/37\">",
"       37",
"      </a>",
"      ]. Symptoms of hypothyroidism are uncommon, but this problem may contribute to the growth impairment.",
"     </li>",
"     <li>",
"      Pancreas &mdash; Insulin-dependent diabetes has been reported, primarily in cystinotic patients on peritoneal dialysis or after kidney transplantation when high doses of corticosteroids are given to treat acute rejection [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/38\">",
"       38",
"      </a>",
"      ]. The hyperglycemia is usually transient, although a few patients require chronic insulin therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/39\">",
"       39",
"      </a>",
"      ]. Exocrine pancreatic insufficiency with steatorrhea has been reported in one patient [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Muscle &mdash; Muscular weakness is seen in affected patients and is due initially to hypokalemia and to",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/11/22710?source=see_link\">",
"       carnitine",
"      </a>",
"      deficiency. Older children may develop a myopathy, which may cause respiratory insufficiency, secondary to cystine crystal accumulation in the muscle cells [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Gonads &mdash; Low plasma testosterone levels and delayed pubertal development is a common finding in older boys [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/42,43\">",
"       42,43",
"      </a>",
"      ]. This complication, which may persist after renal transplantation, reflects testicular disease induced at least in part by cystine deposition, since pituitary function appears to be intact [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/42\">",
"       42",
"      </a>",
"      ]. The mean age of puberty in affected females is 15 years [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/43\">",
"       43",
"      </a>",
"      ], and successful pregnancies have been reported in women with cystinosis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/44,45\">",
"       44,45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Neurologic &mdash; Children with cystinosis have normal cognitive function [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/46\">",
"       46",
"      </a>",
"      ]. Central nervous system involvement is a late complication that occurs after age 20 [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/47-49\">",
"       47-49",
"      </a>",
"      ]. The main symptoms are difficulty in walking and swallowing [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/50,51\">",
"       50,51",
"      </a>",
"      ], progressive loss of speech, memory loss, diminished intellectual function, and dementia. Pyramidal signs, cranial nerve defects, dysphagia, and dysarthria also may be seen. Findings detected by computed tomography (CT) or magnetic resonance imaging (MRI) include cerebral atrophy, dilated ventricles, basal ganglia calcifications, and patchy areas of demyelination.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     INTERMEDIATE AND ADULT CYSTINOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical course is more indolent in the forms of cystinosis that present in older patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intermediate cystinosis &mdash; The first symptoms of adolescent cystinosis typically appear at age 8. The manifestations of the Fanconi syndrome are less severe or absent, and end-stage renal disease occurs after the age of 15 years [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/52,53\">",
"       52,53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Adult cystinosis &mdash; Adult cystinotics are generally asymptomatic. They may suffer from photophobia, with the diagnosis being made by the observation of corneal crystal deposits by the ophthalmologist.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical presentation of late-onset cystinosis was reviewed in 14 patients from nine unrelated families who were between 4 and 23 years of age at the time of diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/31\">",
"     31",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At presentation, 10 patients had symptoms of ocular discomfort and photophobia, In addition, all patients had cystine corneal deposits on slit-lamp examination and proteinuria; eight also had Fanconi syndrome.",
"     </li>",
"     <li>",
"      End-stage renal disease developed in four patients between 12 to 28 years of life. In addition, renal transplantation was performed in four other patients including one patient who was diagnosed with cystinosis after transplantation. The reasons for renal transplantation were not included.",
"     </li>",
"     <li>",
"      Genetic screening demonstrated CTNS mutations in seven of the nine families, which were homozygotic in two families, compound heterozygotic in four families, and a single heterozygous mutation in one family.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of cystinosis can be confirmed by determining the cystine content of peripheral blood leukocyte or fibroblasts [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. The assay using the cystine binding protein is more sensitive and permits the detection of heterozygous carriers. The intraleukocyte cystine content is 5 to 15 nmol of",
"    <span class=\"nowrap\">",
"     half-cystine/mg",
"    </span>",
"    protein in the infantile form, 3 to 6 in the intermediate form, less than 1 in heterozygous carriers, and less than 0.2 in normal individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/56\">",
"     56",
"    </a>",
"    ]. A 2004 National Institutes of Health Cystinosis Conference suggested that an elevated leukocyte cystine level at any age (approximately 3 to 20 nmol of",
"    <span class=\"nowrap\">",
"     half-cystine/mg",
"    </span>",
"    protein) provides a definitive diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prenatal diagnosis of an at-risk fetus can be established in the first trimester by molecular methods measuring 35S-labeled cystine incorporation into fibroblasts cultured from amniotic fluid or chorionic villi, directly or after culture [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy of cystinosis consists of both amelioration of symptoms, the administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    , and renal transplantation for those who progress to end-stage renal disease. A new therapeutic approach using bone marrow cell transplantation was tested on a knock-out mouse model of cystinosis with encouraging results [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Symptomatic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial aim of the symptomatic treatment in infantile cystinosis is to replace the fluid and electrolyte losses induced by the proximal dysfunction. Water intake has to be adjusted according to the urine output, and should be increased during episodes of fever. Sodium and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/26/42402?source=see_link\">",
"     potassium bicarbonate",
"    </a>",
"    supplements are given in order to maintain the plasma bicarbonate concentration between 21 and 24",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    and to correct hypokalemia. Some patients require as much as 10 to 15",
"    <span class=\"nowrap\">",
"     mEq/kg",
"    </span>",
"    or bicarbonate per day, since raising the plasma bicarbonate concentration above the reduced tubular reabsorptive capacity results in the rapid excretion of the exogenous bicarbonate in the urine.",
"   </p>",
"   <p>",
"    Tubular losses of water, sodium, and potassium may be drastically reduced by",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/27/17848?source=see_link\">",
"     indomethacin",
"    </a>",
"    in a dose of 1 to 3",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/59\">",
"     59",
"    </a>",
"    ]. This regimen frequently allows tube feeding, which is necessary in most patients, to be discontinued. It also improves appetite and growth. Fluid and electrolyte losses and therefore the need for supplementation also diminish with age due to the progressive decline in glomerular filtration rate.",
"   </p>",
"   <p>",
"    Other supplements are also required in affected children. These include phosphate (1 to 3",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    to maintain the phosphate plasma level above 3.7",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.2",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and prevent rickets, calcium, magnesium, and vitamin D. Vitamin D can be given as 10 to 25",
"    <span class=\"nowrap\">",
"     mcg/day",
"    </span>",
"    of calcidiol (25-hydroxyvitamin D) or in a starting dose of 0.25",
"    <span class=\"nowrap\">",
"     mcg/day",
"    </span>",
"    of calcitriol (1,25 dihydroxyvitamin D). The dose of vitamin D should be adjusted according to the plasma calcium concentration.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/11/22710?source=see_link\">",
"     L-carnitine",
"    </a>",
"    supplementation is recommended, with a starting dose of 50 to 100",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day titrated to maintain plasma",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/11/22710?source=see_link\">",
"     carnitine",
"    </a>",
"    levels in the normal range [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/60\">",
"     60",
"    </a>",
"    ]. Thyroxine replacement is indicated in children with hypothyroidism. Growth hormone therapy is also safe and effective. Treatment should be started early in the course of the disease if adequate nutrition and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    treatment do not prevent growth retardation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Cysteamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    directly treats the disease by reducing the intracellular cystine content. Cysteamine enters the cell and concentrates within the lysosomes, where it reacts with cystine to form both cysteine and a cysteine-cysteamine complex that are able to leave the lysosomes.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     Cysteamine",
"    </a>",
"    should be started as soon as the diagnosis of cystinosis is confirmed as it preserves renal function, prevents hypothyroidism, and improves growth in affected children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. However, cysteamine treatment does not prevent the occurrence of the Fanconi syndrome. The preservation of renal function was demonstrated in a study of 76 patients who were treated at the National Institutes of Health [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/62\">",
"     62",
"    </a>",
"    ]. At a mean of 8.3 years, patients who were treated early and adequately had a higher mean creatinine clearance than those who never received cysteamine (56 versus 8",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m2).",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     Cysteamine",
"    </a>",
"    treatment has no effect on preexisting fluid and electrolyte losses nor does it prevent tubular dysfunction, even when started after birth in children who have been diagnosed antenatally. However, children treated adequately (as assessed by depletion of cystine from leukocytes) and early, show improved growth and maintenance of the glomerular filtration rate and are less likely to develop hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Poorly compliant patients and those treated at an older age do not have as great a benefit, although the rate of progression to renal failure is slowed [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The long-term effects of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    were evaluated in 86 adult patients (mean age 26.7 years) diagnosed with nephropathic cystinosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/65\">",
"     65",
"    </a>",
"    ]. In this cohort, initiating cysteamine therapy before five years of age significantly decreased the incidence and delayed the onset of end-stage renal disease, and delayed the onset of hypothyroidism, diabetes, and neuromuscular disorders. In addition, the life expectancy was significantly improved in cysteamine-treated versus untreated patients. Cysteamine appeared to slow the progress of swallowing dysfunction in one uncontrolled study of 101 patients with nephropathic cystinosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/51\">",
"     51",
"    </a>",
"    ]. Topical but not systemic cysteamine is effective in preventing corneal crystal deposition and in reducing photophobia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Dosing and formulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dose of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    should be progressively increased from 10 to 50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day (maximum dose of 1.95",
"    <span class=\"nowrap\">",
"     gm/m2",
"    </span>",
"    per day). The drug is rapidly absorbed and its effect lasts for only six hours. It should therefore be given every six hours to prevent intracellular cystine accumulation. Levels of cystine are measured in white blood cell and the optimal level is less than 1 nmol",
"    <span class=\"nowrap\">",
"     half-cystine/mg",
"    </span>",
"    protein.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     Cysteamine",
"    </a>",
"    bitartrate (Cystagon) is available and patients seem to be more compliant with this formulation, which also requires administration every six hours.",
"   </p>",
"   <p>",
"    Although not yet available for commercial use, an enteric-release formulation of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    bitartrate (mean daily dose of 28.8",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    body) administered as two doses every 12 hours was as effective as the current formulation of cysteamine given every six hours in maintaining white blood cystine levels within a satisfactory range [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. There was no significant deterioration in renal or thyroid function and there were fewer side effects with the long-acting cysteamine bitartrate in comparison to the standard formulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H528020669\">",
"    <span class=\"h3\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Side effects of the drug include nausea and vomiting and can be managed with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/23/24952?source=see_link\">",
"     omeprazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/69\">",
"     69",
"    </a>",
"    ]. Less commonly, allergic rashes, seizures, and neutropenia are seen. In addition,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    is responsible for an unpleasant breath odor so that long-term compliance is difficult to maintain, especially in adolescents [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other side effects, such as including bruise-like skin lesions at the elbow and knee due to vascular proliferation, neurologic symptoms, and muscle pain have been reported when the dosing exceeds the maximum daily dose of 1.95",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/71\">",
"     71",
"    </a>",
"    ]. In most cases, these side effects resolved with a reduction in",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    dosing. In patients with drug toxicity, a dose reduction of 25 percent based on body surface area is suggested with careful monitoring of intraleukocyte cystine content to ensure that underdosing does not occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Renal transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific requirements for the treatment of cystinotic patients with end-stage renal disease. Renal transplantation is more successful in cystinosis than in other causes of renal failure in children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/55,72,73\">",
"     55,72,73",
"    </a>",
"    ]. This may be related to diminished immune responsiveness induced by intracellular cystine accumulation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/74\">",
"     74",
"    </a>",
"    ]. Cystine-induced tubular dysfunction does not recur on the graft, although cystine does accumulate in the interstitial cells.",
"   </p>",
"   <p>",
"    However, there is considerable long-term morbidity from extrarenal cystinosis following renal transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/73,75,76\">",
"     73,75,76",
"    </a>",
"    ]. In one study of 36 patients, for example, 31 percent were taking thyroid hormone replacement, 21 had moderate to severe swallowing abnormalities, eight had cerebral calcifications, and five were blind [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/73\">",
"     73",
"    </a>",
"    ]. Few patients over the age of 20 had no serious complications and those over the age of 30 were usually doing poorly, although many were still working. Lack of prolonged compliance with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    therapy may have been a major cause of these problems, as only 11 patients received adequate treatment. It is estimated that depletion of excess cystine from muscle requires four to eleven years of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the availability of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    , significant morbidity and mortality remain in patients with cystinosis. Long-term sustained cysteamine therapy into adulthood appears to improve patient outcome.",
"   </p>",
"   <p>",
"    The outcome of patients and effects of oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"     cysteamine",
"    </a>",
"    therapy were evaluated in a large case series of 100 patients who were enrolled in the National Institutes cysteamine trial from 1985 to 2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12584/abstract/77\">",
"     77",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Renal transplantation was performed in 92 patients at a mean age of 12.3 years.",
"     </li>",
"     <li>",
"      Thirty-three patients died at a mean age of 28.5 years (range 18 to 43 years).",
"     </li>",
"     <li>",
"      Patients had significant nonrenal abnormalities including hypothyroidism (75 percent), pulmonary insufficiency (69 percent), swallowing abnormalities (60 percent), myopathy (50 percent), hypercholesterolemia (33 percent), retinopathy (32 percent), vascular (31 percent) and cerebral calcifications (22 percent), and diabetes mellitus (24 percent). Hypergonadotropic hypogonadism was present in 74 percent of males.",
"     </li>",
"     <li>",
"      Patients who received sustained long-term oral",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"       cysteamine",
"      </a>",
"      therapy (greater than eight years) compared to those receiving a shorter course had better growth, renal transplantation at a later age, lower cholesterol levels, fewer complications, and a lower mortality rate. The frequency of diabetes mellitus, myopathy, pulmonary dysfunction, hypothyroidism, and death increased as the duration of time off of cysteamine therapy increased.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystinosis is a metabolic disease characterized by an accumulation of cystine in different organs and tissues leading to potentially severe organ dysfunction including end-stage renal disease (ESRD).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cystinosis is an autosomal recessive trait that is due to mutations of the CTNS gene, which encodes cystinosin. Cystinosin is a novel transporter that is responsible for exporting cystine from lysosomes. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cystinosis is classified into three forms based upon the age of presentation and severity of symptoms: the infantile (nephropathic) form, the intermediate (adolescent, late-onset) form; and the adult (benign) form.",
"     </li>",
"     <li>",
"      Infantile cystinosis is the most common and severe phenotype. Patients present between three and six months of age with signs and symptoms due to renal tubular dysfunction. These include polyuria, polydipsia, poor weight gain, vomiting, weakness, unexplained fever, and acute episodes of hypovolemia. These children have a progressive decline in glomerular filtration rate (GFR) resulting in ESRD by 10 years of age. Nonrenal findings include ocular abnormalities, hepatomegaly, hypothyroidism, muscle weakness, and growth retardation. Although cognitive function is normal in children, complications of the central nervous system occur after 20 years of age. In affected males, delayed puberty is common. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Infantile cystinosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intermediate cystinosis generally presents around eight years of age with manifestations due to renal tubular dysfunction. These patients also have a progressive decline in GFR resulting in ESRD by 15 years of age. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Intermediate and adult cystinosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adult cystinosis is the most benign form. Patients are generally asymptomatic except for photophobia or ocular discomfort due to crystal deposition in their cornea. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Intermediate and adult cystinosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of cystinosis is confirmed by elevated intraleukocyte cystine content. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend treating all patients with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/61/7124?source=see_link\">",
"       cysteamine",
"      </a>",
"      as soon as the diagnosis of cystinosis is confirmed. Early treatment with cysteamine preserves renal function, prevents hypothyroidism, reduces ocular discomfort and prevents visual impairment, and improves growth and survival. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Cysteamine'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who develop ESRD, the outcome for renal transplantation is better than other causes of ESRD. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Renal transplantation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/1\">",
"      Middleton R, Bradbury M, Webb N, et al. Cystinosis. A clinicopathological conference. \"From toddlers to twenties and beyond\" Adult-Paediatric Nephrology Interface Meeting, Manchester 2001. Nephrol Dial Transplant 2003; 18:2492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/2\">",
"      Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med 2002; 347:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/3\">",
"      Bois E, Feingold J, Frenay P, Briard ML. Infantile cystinosis in France: genetics, incidence, geographic distribution. J Med Genet 1976; 13:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/4\">",
"      Manz F, Gretz N. Cystinosis in the Federal Republic of Germany. Coordination and analysis of the data. J Inherit Metab Dis 1985; 8:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/5\">",
"      Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000; 58:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/6\">",
"      Gahl WA, Bashan N, Tietze F, et al. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 1982; 217:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/7\">",
"      Gahl WA, Tietze F, Bashan N, et al. Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. J Biol Chem 1982; 257:9570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/8\">",
"      Jonas AJ, Smith ML, Schneider JA. ATP-dependent lysosomal cystine efflux is defective in cystinosis. J Biol Chem 1982; 257:13185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/9\">",
"      Jonas AJ, Smith ML, Allison WS, et al. Proton-translocating ATPase and lysosomal cystine transport. J Biol Chem 1983; 258:11727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/10\">",
"      Thoene JG, Oshima RG, Ritchie DG, Schneider JA. Cystinotic fibroblasts accumulate cystine from intracellular protein degradation. Proc Natl Acad Sci U S A 1977; 74:4505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/11\">",
"      Park MA, Pejovic V, Kerisit KG, et al. Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of protein kinase Cdelta. J Am Soc Nephrol 2006; 17:3167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/12\">",
"      Foreman JW, Bowring MA, Lee J, et al. Effect of cystine dimethylester on renal solute handling and isolated renal tubule transport in the rat: a new model of the Fanconi syndrome. Metabolism 1987; 36:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/13\">",
"      Cetinkaya I, Schlatter E, Hirsch JR, et al. Inhibition of Na(+)-dependent transporters in cystine-loaded human renal cells: electrophysiological studies on the Fanconi syndrome of cystinosis. J Am Soc Nephrol 2002; 13:2085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/14\">",
"      Figueiredo VC, Feksa LR, Wannmacher CM. Cysteamine prevents inhibition of adenylate kinase caused by cystine in rat brain cortex. Metab Brain Dis 2009; 24:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/15\">",
"      Feksa LR, Cornelio A, Dutra-Filho CS, et al. Inhibition of pyruvate kinase activity by cystine in brain cortex of rats. Brain Res 2004; 1012:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/16\">",
"      Fleck RM, Rodrigues Junior V, Giacomazzi J, et al. Cysteamine prevents and reverses the inhibition of creatine kinase activity caused by cystine in rat brain cortex. Neurochem Int 2005; 46:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/17\">",
"      Pereira Oliveira PR, Rodrigues-Junior V, Rech VC, Duval Wannmacher CM. Cystine inhibits creatine kinase activity in pig retina. Arch Med Res 2007; 38:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/18\">",
"      Chol M, Nevo N, Cherqui S, et al. Glutathione precursors replenish decreased glutathione pool in cystinotic cell lines. Biochem Biophys Res Commun 2004; 324:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/19\">",
"      Thoene JG. A review of the role of enhanced apoptosis in the pathophysiology of cystinosis. Mol Genet Metab 2007; 92:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/20\">",
"      Devonald MA, Karet FE. Renal epithelial traffic jams and one-way streets. J Am Soc Nephrol 2004; 15:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/21\">",
"      Pellett OL, Smith ML, Greene AA, Schneider JA. Lack of complementation in somatic cell hybrids between fibroblasts from patients with different forms of cystinosis. Proc Natl Acad Sci U S A 1988; 85:3531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/22\">",
"      Town M, Jean G, Cherqui S, et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 1998; 18:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/23\">",
"      Haq MR, Kalatzis V, Gubler MC, et al. Immunolocalization of cystinosin, the protein defective in cystinosis. J Am Soc Nephrol 2002; 13:2046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/24\">",
"      Cherqui S, Kalatzis V, Trugnan G, Antignac C. The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif. J Biol Chem 2001; 276:13314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/25\">",
"      Kalatzis V, Cherqui S, Antignac C, Gasnier B. Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J 2001; 20:5940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/26\">",
"      Anikster Y, Shotelersuk V, Gahl WA. CTNS mutations in patients with cystinosis. Hum Mutat 1999; 14:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/27\">",
"      Attard M, Jean G, Forestier L, et al. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet 1999; 8:2507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/28\">",
"      Anikster Y, Lucero C, Guo J, et al. Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations. Pediatr Res 2000; 47:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/29\">",
"      Forestier L, Jean G, Attard M, et al. Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay. Am J Hum Genet 1999; 65:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/30\">",
"      Thoene J, Lemons R, Anikster Y, et al. Mutations of CTNS causing intermediate cystinosis. Mol Genet Metab 1999; 67:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/31\">",
"      Servais A, Morini&egrave;re V, Gr&uuml;nfeld JP, et al. Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping. Clin J Am Soc Nephrol 2008; 3:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/32\">",
"      Schneider JA, Katz B, Melles RB. Update on nephropathic cystinosis. Pediatr Nephrol 1990; 4:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/33\">",
"      Knoepfelmacher M, Rocha R, Salgado LR, et al. [Nephropathic cystinosis: report of 2 cases and review of the literature]. Rev Assoc Med Bras 1994; 40:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/34\">",
"      Lemire J, Kaplan BS. The various renal manifestations of the nephropathic form of cystinosis. Am J Nephrol 1984; 4:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/35\">",
"      Dufier JL, Dhermy P, Gubler MC, et al. Ocular changes in long-term evolution of infantile cystinosis. Ophthalmic Paediatr Genet 1987; 8:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/36\">",
"      Kaiser-Kupfer MI, Caruso RC, Minkler DS, Gahl WA. Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol 1986; 104:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/37\">",
"      Burke JR, El-Bishti MM, Maisey MN, Chantler C. Hypothyroidism in children with cystinosis. Arch Dis Child 1978; 53:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/38\">",
"      Fivush B, Green OC, Porter CC, et al. Pancreatic endocrine insufficiency in posttransplant cystinosis. Am J Dis Child 1987; 141:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/39\">",
"      Robert JJ, T&ecirc;te MJ, Guest G, et al. Diabetes mellitus in patients with infantile cystinosis after renal transplantation. Pediatr Nephrol 1999; 13:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/40\">",
"      Fivush B, Flick JA, Gahl WA. Pancreatic exocrine insufficiency in a patient with nephropathic cystinosis. J Pediatr 1988; 112:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/41\">",
"      Gahl WA, Dalakas MC, Charnas L, et al. Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis. N Engl J Med 1988; 319:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/42\">",
"      Chik CL, Friedman A, Merriam GR, Gahl WA. Pituitary-testicular function in nephropathic cystinosis. Ann Intern Med 1993; 119:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/43\">",
"      Winkler L, Offner G, Krull F, Brodehl J. Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr 1993; 152:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/44\">",
"      Andrews PA, Sacks SH, van't Hoff W. Successful pregnancy in cystinosis. JAMA 1994; 272:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/45\">",
"      Reiss RE, Kuwabara T, Smith ML, Gahl WA. Successful pregnancy despite placental cystine crystals in a woman with nephropathic cystinosis. N Engl J Med 1988; 319:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/46\">",
"      Wolff G, Ehrich JH, Offner G, Brodehl J. Psychosocial and intellectual development in 12 patients with infantile nephropathic cystinosis. Acta Paediatr Scand 1982; 71:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/47\">",
"      Cochat P, Drachman R, Gagnadoux MF, et al. Cerebral atrophy and nephropathic cystinosis. Arch Dis Child 1986; 61:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/48\">",
"      Jonas AJ, Conley SB, Marshall R, et al. Nephropathic cystinosis with central nervous system involvement. Am J Med 1987; 83:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/49\">",
"      Fink JK, Brouwers P, Barton N, et al. Neurologic complications in long-standing nephropathic cystinosis. Arch Neurol 1989; 46:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/50\">",
"      Sonies BC, Ekman EF, Andersson HC, et al. Swallowing dysfunction in nephropathic cystinosis. N Engl J Med 1990; 323:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/51\">",
"      Sonies BC, Almajid P, Kleta R, et al. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Medicine (Baltimore) 2005; 84:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/52\">",
"      Langman CB, Moore ES, Thoene JG, Schneider JA. Renal failure in a sibship with late-onset cystinosis. J Pediatr 1985; 107:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/53\">",
"      Goldman H, Scriver CR, Aaron K, et al. Adolescent cystinosis: comparisons with infantile and adult forms. Pediatrics 1971; 47:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/54\">",
"      Oshima RG, Willis RC, Furlong CE, Schneider JA. Binding assays for amino acids. The utilization of a cystine binding protein from Escherichia coli for the determination of acid-soluble cystine in small physiological samples. J Biol Chem 1974; 249:6033.",
"     </a>",
"    </li>",
"    <li>",
"     Kleta, R, Kaskel, F, Dohil, R, et al. First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/56\">",
"      Smolin LA, Clark KF, Schneider JA. An improved method for heterozygote detection of cystinosis, using polymorphonuclear leukocytes. Am J Hum Genet 1987; 41:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/57\">",
"      Jackson M, Young E. Prenatal diagnosis of cystinosis by quantitative measurement of cystine in chorionic villi and cultured cells. Prenat Diagn 2005; 25:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/58\">",
"      Syres K, Harrison F, Tadlock M, et al. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 2009; 114:2542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/59\">",
"      Haycock GB, Al-Dahhan J, Mak RH, Chantler C. Effect of indomethacin on clinical progress and renal function in cystinosis. Arch Dis Child 1982; 57:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/60\">",
"      Gahl WA, Bernardini IM, Dalakas MC, et al. Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis. Pediatr Res 1993; 34:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/61\">",
"      W&uuml;hl E, Haffner D, Offner G, et al. Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr 2001; 138:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/62\">",
"      Markello TC, Bernardini IM, Gahl WA. Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 1993; 328:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/63\">",
"      Kimonis VE, Troendle J, Rose SR, et al. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab 1995; 80:3257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/64\">",
"      Smolin LA, Clark KF, Thoene JG, et al. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr Res 1988; 23:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/65\">",
"      Brodin-Sartorius A, T&ecirc;te MJ, Niaudet P, et al. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int 2012; 81:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/66\">",
"      Kaiser-Kupfer MI, Fujikawa L, Kuwabara T, et al. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med 1987; 316:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/67\">",
"      Dohil R, Fidler M, Gangoiti JA, et al. Twice-daily cysteamine bitartrate therapy for children with cystinosis. J Pediatr 2010; 156:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/68\">",
"      Langman CB, Greenbaum LA, Sarwal M, et al. A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. Clin J Am Soc Nephrol 2012; 7:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/69\">",
"      Dohil R, Newbury RO, Sellers ZM, et al. The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine. J Pediatr 2003; 143:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/70\">",
"      Schneider JA. Treatment of cystinosis: simple in principle, difficult in practice. J Pediatr 2004; 145:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/71\">",
"      Besouw MT, Bowker R, Dutertre JP, et al. Cysteamine toxicity in patients with cystinosis. J Pediatr 2011; 159:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/72\">",
"      Broyer M. Kidney transplantation in children--data from the EDTA registry. The EDTA Registry Committee. Transplant Proc 1989; 21:1985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/73\">",
"      Theodoropoulos DS, Krasnewich D, Kaiser-Kupfer MI, Gahl WA. Classic nephropathic cystinosis as an adult disease. JAMA 1993; 270:2200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/74\">",
"      Pintos-Morell G, Jean G, Dechaux M, Niaudet P. Increased monocyte-dependent suppression of polyclonal activation of B lymphocytes from cystinotic children. Pediatr Nephrol 1991; 5:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/75\">",
"      Geelen JM, Monnens LA, Levtchenko EN. Follow-up and treatment of adults with cystinosis in the Netherlands. Nephrol Dial Transplant 2002; 17:1766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/76\">",
"      Ueda M, O'Brien K, Rosing DR, et al. Coronary artery and other vascular calcifications in patients with cystinosis after kidney transplantation. Clin J Am Soc Nephrol 2006; 1:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12584/abstract/77\">",
"      Gahl WA, Balog JZ, Kleta R. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intern Med 2007; 147:242.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6139 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-89.32.226.102-9F539080E8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12584=[""].join("\n");
var outline_f12_18_12584=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Infantile form",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Intermediate form",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Adult cystinosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INFANTILE CYSTINOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Renal symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Extrarenal symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      INTERMEDIATE AND ADULT CYSTINOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Symptomatic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Cysteamine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Dosing and formulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H528020669\">",
"      - Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Renal transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_18_12585="Histology case 6";
var content_f12_18_12585=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F79759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F79759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Histology case 6",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 401px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panels A and B show the respective light micrograph and the immunofluoresence microscopy in two patients. The immunofluorescence in panel A was obtained from renal tissue while that in panel B from the patient's white cells. Immunofluorescence microscopy of the kidney in the case in panel B was negative.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12585=[""].join("\n");
var outline_f12_18_12585=null;
var title_f12_18_12586="Mastectomy";
var content_f12_18_12586=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mastectomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/18/12586/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/18/12586/contributors\">",
"     Ava Kwong, MBBS, BSc, FRCS, FCSHK, FHKAM",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/18/12586/contributors\">",
"     Michael S Sabel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/18/12586/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/18/12586/contributors\">",
"     Anees B Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/18/12586/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/18/12586/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/18/12586/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H14332858\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical management options for breast cancer include mastectomy or breast conserving therapy. BCT refers to surgical removal of the tumor (with negative surgical margins) followed by moderate-dose radiation therapy to eradicate any residual disease. Breast conserving therapy is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=see_link\">",
"     \"Breast conserving therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will address the types of mastectomy, the choice of mastectomy, and the techniques and complications of mastectomy. The diagnostic evaluation of women with suspected breast cancer and the medical management of breast cancer are addressed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/36/24138?source=see_link\">",
"     \"Diagnostic evaluation of women with suspected breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/46/19177?source=see_link\">",
"     \"Overview of the treatment of newly diagnosed, non-metastatic breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10264077\">",
"    <span class=\"h1\">",
"     MULTIDISCIPLINARY COORDINATION FOR BREAST CANCER PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis of cancer is made, multidisciplinary coordination among breast and reconstructive surgeons, radiation and medical oncologists, and radiologists and pathologists facilitates treatment planning and streamlines patient care [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/46/19177?source=see_link\">",
"     \"Overview of the treatment of newly diagnosed, non-metastatic breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/36/24138?source=see_link\">",
"     \"Diagnostic evaluation of women with suspected breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neoadjuvant systemic therapy may preclude the need for mastectomy and allow breast conserving therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H11989615#H11989615\">",
"     \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Patient selection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=see_link\">",
"     \"Breast conserving therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Postmastectomy radiation is indicated for patients at high risk for local recurrence, such as those with T3 or T4 tumors, positive deep margins, and positive axillary lymph nodes. If postmastectomy radiation is likely, this may affect the choice of mastectomy type, the choice of the reconstructive approach, and optimal timing of the breast reconstruction (immediate versus delayed). Thus,",
"    <strong>",
"     preoperative",
"    </strong>",
"    coordination of care assures the best outcome. Postmastectomy radiation is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/3/41017?source=see_link&amp;anchor=H18#H18\">",
"     \"Postmastectomy chest wall irradiation\", section on 'Indications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39386?source=see_link&amp;anchor=H2464163#H2464163\">",
"     \"Breast reconstruction in women with breast cancer\", section on 'Radiation therapy and reconstruction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1378592045\">",
"    <span class=\"h1\">",
"     SELECTION CRITERIA FOR MASTECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mastectomy is indicated for patients who are not candidates for breast conserving therapy, patients who prefer mastectomy, and for prophylactic purposes as discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121293930\">",
"    <span class=\"h2\">",
"     Breast conservation is contraindicated or unsuccessful",
"    </span>",
"    &nbsp;&mdash;&nbsp;The criteria that preclude breast conservation are presented here briefly and addressed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=see_link&amp;anchor=H7#H7\">",
"     \"Breast conserving therapy\", section on 'Patient selection for BCT'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multicentric disease with two or more primary tumors in separate quadrants of the breast.",
"     </li>",
"     <li>",
"      Large tumor size in relation to breast size, although neoadjuvant systemic treatment may downstage large tumors and improve the chances for successful breast conserving surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=see_link&amp;anchor=H89686878#H89686878\">",
"       \"Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options\", section on 'Inoperable disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diffuse malignant microcalcifications on mammography. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/36/24138?source=see_link&amp;anchor=H5#H5\">",
"       \"Diagnostic evaluation of women with suspected breast cancer\", section on 'Mammographic features of breast cancer'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A history of prior therapeutic radiation that included a portion of the affected breast, which when combined with the proposed treatment, would result in an excessively high total radiation dose to the chest wall. This includes patients who had prior breast radiation as well as those who received chest wall radiation for other reasons, such as mantle radiation for Hodgkin&rsquo;s lymphoma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/26/35242?source=see_link&amp;anchor=H25#H25\">",
"       \"Second malignancies after treatment of classical Hodgkin lymphoma\", section on 'Breast cancer'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pregnancy is an absolute contraindication to the use of breast irradiation; however, it may be possible to perform breast-conserving surgery in the third trimester, deferring breast irradiation until after delivery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17207?source=see_link\">",
"       \"Breast cancer during pregnancy and lactation: Epidemiology and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Persistently positive resection margins after reasonable attempts at reexcision.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121293916\">",
"    <span class=\"h2\">",
"     Patient choice",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients may choose to have a mastectomy rather than breast conserving therapy for various reasons, including a desire to avoid the need for postoperative radiation, further screening, or biopsies, as well as to reduce the risk of local recurrence. Patients should be presented with the advantages and disadvantages of the two approaches when both breast conserving surgery and mastectomy are clinically and oncologically acceptable. This should include discussion of cosmetic concerns, because breast conserving surgery may result in unacceptable cosmetic results if the patient has a small amount of breast tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121293923\">",
"    <span class=\"h2\">",
"     Prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with hereditary breast and ovarian syndrome and patients with mutations of the breast cancer type 1 and 2 susceptibility genes (BRCA1 and BRCA2), a prophylactic mastectomy reduces the risk of developing breast cancer. Skin-sparing mastectomy with or without preservation of the nipple-areolar complex and immediate reconstruction provides superior cosmetic results for these patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17418?source=see_link&amp;anchor=H2#H2\">",
"     \"Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations\", section on 'Risk-reducing surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A contralateral mastectomy may be indicated in such patients who have been diagnosed with unilateral breast cancer, such as for those who carry a deleterious BRCA1 or BRCA2 mutation. However, in a matched control study that included 355 women with breast cancer, women who underwent a contralateral prophylactic mastectomy did not have an improved overall, disease-free, or distant metastasis-free survival in comparison with women who had a unilateral mastectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17418?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations\", section on 'Treatment and prognosis of women who develop breast cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7005266\">",
"    <span class=\"h1\">",
"     TYPES OF MASTECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mastectomy is the complete surgical resection of the breast tissue. In most cases, mastectomy also includes removal of the nipple-areolar complex, some overlying skin, and the pectoral fascia. Types of mastectomy include radical mastectomy, modified radical mastectomy, simple mastectomy, skin-sparing mastectomy, and nipple-sparing mastectomy. The choice of mastectomy depends on the clinical scenario. (See",
"    <a class=\"local\" href=\"#H7006000\">",
"     'Choice of mastectomy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The differences between the types of mastectomy are explained below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7005293\">",
"    <span class=\"h2\">",
"     Radical mastectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A radical mastectomy (Halsted mastectomy) consists of en bloc removal of the breast, the overlying skin, the pectoralis major and minor muscles, and the entire axillary contents (level I, II, and III nodes). This extensive resection was originally proposed to provide a better chance of disease control than lumpectomy alone and was the standard of care for treating breast cancer for many years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/3\">",
"     3",
"    </a>",
"    ]. However, despite improved local control, the curative potential of this operation remained limited. In a series that followed 1438 women who had undergone radical mastectomy over 30 years, only 13 percent were free of disease and 57 percent had died of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/4\">",
"     4",
"    </a>",
"    ]. Attempts to further expand the field of resection by including the internal mammary nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/5\">",
"     5",
"    </a>",
"    ] failed to improve survival [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/6\">",
"     6",
"    </a>",
"    ]. Radical mastectomy is rarely used today.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7005300\">",
"    <span class=\"h2\">",
"     Modified radical mastectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A modified radical mastectomy (MRM) is complete removal of the breast and the underlying fascia of the pectoralis major muscle along with the removal of the level I and II axillary lymph nodes. Several randomized trials documented equivalent survival rates with MRM as compared to radical mastectomy, with less morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. The equivalent survival outcome of the two procedures was further confirmed in an analysis of 3236 women enrolled in four randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. As a result of these data, radical mastectomy is rarely performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7005307\">",
"    <span class=\"h2\">",
"     Simple mastectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A total or simple mastectomy is removal of the entire breast, with preservation of the pectoral muscles and the axillary contents. The difference between MRM and a simple mastectomy is that the former includes axillary dissection (level I and level II axillary dissection being the standard procedure). With the emergence of sentinel node biopsy, simple mastectomy is performed more frequently than a MRM. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36602?source=see_link\">",
"     \"Sentinel lymph node dissection for breast cancer: Indications and outcomes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20296?source=see_link\">",
"     \"Sentinel lymph node biopsy in breast cancer: Techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7005314\">",
"    <span class=\"h2\">",
"     Skin-sparing mastectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The \"skin-sparing\" mastectomy (SSM) is a surgical technique in which the majority of the natural breast skin envelope is not resected; in contrast, a conventional mastectomy incision removes a larger portion of the overlying skin [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. The breast parenchyma is excised, usually through a circular incision around the nipple areolar complex, with a lateral extension if needed to access the axilla (",
"    <a class=\"graphic graphic_figure graphicRef71134 \" href=\"UTD.htm?8/36/8772\">",
"     figure 1",
"    </a>",
"    ). In some cases, the existing biopsy scar",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the skin overlying the tumor is also excised. A reconstructive procedure using autogenous tissue is typically performed in the same setting as a SSM. Preservation of the skin of the breast and the inframammary fold provides the reconstructed breast with a more natural shape and contour. The superior cosmetic result has resulted in the increasing popularity of this approach in both the United States and Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/15-22\">",
"     15-22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39386?source=see_link&amp;anchor=H20#H20\">",
"     \"Breast reconstruction in women with breast cancer\", section on 'Autogenous tissue reconstruction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This procedure is an oncologically safe and acceptable option for the surgical management of patients with noninvasive breast cancer (DCIS) and stage I, II, or III breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. It is also an acceptable option for high-risk women who prefer a mastectomy as prophylaxis against breast cancer development. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17418?source=see_link&amp;anchor=H2#H2\">",
"     \"Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations\", section on 'Risk-reducing surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Retrospective and prospective studies found that the local recurrence rates following a SSM range from 0 to 7 percent, comparable to a standard mastectomy, provided the dissection between the breast and the skin is meticulously performed [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/14,18,19,23-29\">",
"     14,18,19,23-29",
"    </a>",
"    ]. In a meta-analysis of retrospective studies (median follow-up 37 to 101 months), no significant difference in local recurrence was identified between patients with a SSM and immediate reconstruction (n = 1104) and those undergoing a conventional mastectomy without reconstruction (n = 2635) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Long-term follow-up results support the short-term observational findings. At a mean follow-up of 119 months, a review of 207 patients from a prospectively maintained database reported that the women undergoing a SSM with immediate reconstruction for primary breast cancer had overall local, locoregional, and distant recurrence rates of 2.9, 8.2, and 10.6 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/24\">",
"     24",
"    </a>",
"    ]. The overall recurrence rate of 18.8 percent was significantly associated with axillary lymph node metastasis, higher stage of disease, and higher tumor grade. Of the women with invasive breast cancer (n = 153), 46.4 percent had stage II or III disease and 14.4 percent had multifocal disease, and the local recurrence rate was 3.9 percent. There were no local or locoregional recurrences for women with noninvasive breast cancer, but two women with high-grade intraductal carcinoma developed distant disease.",
"   </p>",
"   <p>",
"    However, SSM is contraindicated for women with inflammatory breast cancer (IBC) because of cancer cell invasion of the dermal lymphatics [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=see_link&amp;anchor=H10#H10\">",
"     \"Inflammatory breast cancer: Clinical features and treatment\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7005321\">",
"    <span class=\"h2\">",
"     Nipple-sparing mastectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A nipple-sparing mastectomy (NSM) preserves the dermis and epidermis of the nipple but removes the major ducts from within the nipple lumen [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/31\">",
"     31",
"    </a>",
"    ]. This approach is an option for carefully selected patients, particularly those who are having surgery for prophylactic purposes and are having immediate reconstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/15,32-38\">",
"     15,32-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    NSM for the treatment of breast cancer is controversial and should be limited to patients with tumors less than 2 cm in size (T1), at least 2 cm from the nipple, not multicentric, with clinically negative lymph nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/39\">",
"     39",
"    </a>",
"    ]. Because this technique results in large flaps, it is primarily useful for women with small to moderate sized breasts with minimal ptosis. In addition, intra-operative core biopsies of the areola and nipple during the NSM are not completely reliable in predicting occult involvement in patients with a breast cancer. In a retrospective review of 58 patients, intra-operative biopsies failed to identify 2 of 17 positive cases, with a false-negative rate of 11.8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/40\">",
"     40",
"    </a>",
"    ]. There were no false positive biopsies in this series.",
"   </p>",
"   <p>",
"    There are no randomized trials of NSM and long-term follow-up in clinical series is limited. However, a number of retrospective series have shown that recurrence rates are acceptable [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/31,41\">",
"     31,41",
"    </a>",
"    ]. As an example, in a study of 246 patients (48 skin-sparing mastectomies, 60 NSM, and 130 modified radical mastectomies) there was no difference in the rate of local recurrence, distant recurrence, or mortality after eight years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7006000\">",
"    <span class=\"h1\">",
"     CHOICE OF MASTECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of mastectomy depends on the clinical scenario.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radical mastectomy is rarely used unless the tumor invades the pectoral muscle.",
"     </li>",
"     <li>",
"      For patients who are not having immediate reconstruction, a modified radical or simple mastectomy is performed. The difference between a modified radical and a simple mastectomy is that the former includes axillary dissection. With the emergence of sentinel node biopsy, simple mastectomy is performed more commonly.",
"     </li>",
"     <li>",
"      For patients having immediate reconstruction, a skin-sparing mastectomy preserves the skin of the breast and the inframammary fold which provides a superior cosmetic result.",
"     </li>",
"     <li>",
"      For patients having mastectomy for prophylactic purposes, a skin-sparing or nipple-sparing mastectomy will provide the best cosmetic result.",
"     </li>",
"     <li>",
"      For select patients (eg, unifocal tumor less than 2 cm in diameter, greater than 2 cm from nipple) who wish to preserve the nipple areolar complex (NAC), MRI was not superior to a clinical breast examination in detecting cancer in or near the NAC. In a retrospective review of 71 patients undergoing 77 mastectomy procedures, 18 (23 percent) had cancer involving or within 1 cm of the NAC, confirmed histopathologically [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/43\">",
"       43",
"      </a>",
"      ]. The preoperative history and physical examination detected 61 percent and MRI detected 56 percent of patients with confirmed NAC involvement. (See",
"      <a class=\"local\" href=\"#H7005321\">",
"       'Nipple-sparing mastectomy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30366169\">",
"    <span class=\"h1\">",
"     SURGICAL ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The surgeon must understand the complex anatomy of the chest wall and axilla in order to ensure removal of all breast tissue with preservation of maximum muscular function and sensation (",
"    <a class=\"graphic graphic_figure graphicRef54961 \" href=\"UTD.htm?42/27/43447\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef58037 \" href=\"UTD.htm?17/5/17493\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef69782 \" href=\"UTD.htm?18/5/18520\">",
"     figure 4",
"    </a>",
"    ). Axillary anatomy and the techniques of sentinel node biopsy and axillary dissection are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20296?source=see_link\">",
"     \"Sentinel lymph node biopsy in breast cancer: Techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20856?source=see_link\">",
"     \"Technique of axillary lymph node dissection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121294283\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30366296\">",
"    <span class=\"h2\">",
"     Mark the site and side",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient should be examined in the perioperative holding area and the breast to be removed should be identified, confirmed with the patient, and marked with a water soluble pen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30366288\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;A preoperative antibiotic that covers skin flora, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    , should be administered within one hour before the incision is made (",
"    <a class=\"graphic graphic_table graphicRef79097 \" href=\"UTD.htm?22/46/23275\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/44-49\">",
"     44-49",
"    </a>",
"    ]. A meta-analysis of the randomized controlled trials of preoperative antibiotics versus placebo in patients undergoing breast surgery found that the use of preoperative antibiotics was associated with a significant reduction in infection (relative risk 0.60; 95% CI 0.45-0.81) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30366280\">",
"    <span class=\"h2\">",
"     Deep venous thrombosis prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients undergoing general anesthesia, primary prophylaxis for prevention of deep venous thrombosis (DVT) should be employed (",
"    <a class=\"graphic graphic_table graphicRef50947 \" href=\"UTD.htm?34/54/35693\">",
"     table 2",
"    </a>",
"    ). We suggest sequential compression devices rather than systemic prophylaxis because the rate of DVT after breast surgery is low and systemic prophylaxis is associated with a high risk of wound hematoma. In one study of 3898 patients undergoing surgery for breast cancer with DVT prophylaxis using compression stockings and early ambulation alone, the DVT rate was 0.16 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/51\">",
"     51",
"    </a>",
"    ]. In a series of 425 breast cancer patients, 19 percent of the 310 patients in the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    group developed a hematoma after surgery as compared with 7 percent of the 102 patients in the compression stocking group [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30366515\">",
"    <span class=\"h1\">",
"     ANESTHETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mastectomy is usually performed under general anesthesia. Single injection paravertebral block at the T4 level is an alternative or adjunct to general anesthesia for breast surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/53-58\">",
"     53-58",
"    </a>",
"    ]. As an example, one randomized trial found significantly shortened recovery times, improved postoperative pain scores with diminished requirements for analgesics, and decreased incidence of vomiting in women undergoing breast surgery with a paravertebral block (T4 paravertebral injection [0.3",
"    <span class=\"nowrap\">",
"     mL/kg,",
"    </span>",
"    0.5 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/60/34758?source=see_link\">",
"     bupivacaine",
"    </a>",
"    ]) compared with those who underwent general anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/55\">",
"     55",
"    </a>",
"    ]. A meta-analysis of 11 studies of paravertebral block in breast surgery demonstrated significant decreases in postoperative pain, analgesic consumption, and postoperative nausea and vomiting as compared with general anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/58\">",
"     58",
"    </a>",
"    ]. Preoperative paravertebral blocks may also reduce the incidence of chronic pain following breast surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/59-61\">",
"     59-61",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    The use of paravertebral block is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18042?source=see_link&amp;anchor=H8#H8\">",
"     \"Peripheral nerve block: Techniques\", section on 'Paravertebral nerve block'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14332888\">",
"    <span class=\"h1\">",
"     SURGICAL TECHNIQUE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H986367396\">",
"    <span class=\"h2\">",
"     Positioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient is positioned supine with her arms extended on padded arm boards at &le;90 degrees abduction from the chest wall. Arm positioning with &gt;90 degrees of abduction increases the potential for stretching the brachial plexus and should be avoided. It is important to position the arm while the patient is awake to make sure the arm is not abducted beyond what is comfortable for the patient, especially if there are preexisting problems with shoulder mobility. The ipsilateral arm can be included in the prepped field, which allows the arm to be mobilized during the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121294083\">",
"    <span class=\"h2\">",
"     Axillary staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient is having a sentinel node biopsy or axillary dissection for staging of the axilla, this can be performed before the mastectomy through a separate axillary incision, or through the mastectomy incision after the breast has been removed depending on whether adequate access to the axilla with appropriate visibility can be obtained through the mastectomy incision [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/62\">",
"     62",
"    </a>",
"    ]. A study of 44 patients showed that the sentinel node biopsy could be removed via the breast incision in 98 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/63\">",
"     63",
"    </a>",
"    ]. However, if a skin-sparing or nipple-sparing mastectomy is planned, access to the axilla may need to be obtained via a separate incision. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20296?source=see_link\">",
"     \"Sentinel lymph node biopsy in breast cancer: Techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20856?source=see_link\">",
"     \"Technique of axillary lymph node dissection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121293956\">",
"    <span class=\"h2\">",
"     Incision",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of incision will depend upon tumor location, tumor size, and whether immediate reconstruction is planned. In most cases, if immediate reconstruction is planned, a skin-sparing mastectomy is preferred because it preserves the skin envelope and provides the best cosmetic result.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For a skin-sparing mastectomy, the incision is usually circular and encompasses the nipple areolar complex (",
"      <a class=\"graphic graphic_figure graphicRef71134 \" href=\"UTD.htm?8/36/8772\">",
"       figure 1",
"      </a>",
"      ). Sentinel node biopsy is usually performed through a separate axillary incision. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36602?source=see_link\">",
"       \"Sentinel lymph node dissection for breast cancer: Indications and outcomes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For a simple or modified radical mastectomy without immediate reconstruction, the most common incision is a transverse or oblique elliptical incision including the tumor mass, with lateral extension towards the axilla (",
"      <a class=\"graphic graphic_figure graphicRef59388 \" href=\"UTD.htm?5/21/5460\">",
"       figure 5",
"      </a>",
"      ). However, the incision planning depends on the tumor location and should be adjusted accordingly (",
"      <a class=\"graphic graphic_figure graphicRef66661 \" href=\"UTD.htm?24/53/25430\">",
"       figure 6",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef81050 \" href=\"UTD.htm?13/49/14102\">",
"       figure 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef69254 \" href=\"UTD.htm?11/28/11714\">",
"       figure 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef61564 \" href=\"UTD.htm?17/6/17510\">",
"       figure 9",
"      </a>",
"      ). The incision should not be extended across the anterior axillary line to avoid scar contractures that could decrease the range of shoulder movement. The axillary lymph nodes are accessed through the mastectomy incision. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20856?source=see_link\">",
"       \"Technique of axillary lymph node dissection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The surgical approach for nipple-sparing mastectomy can be periareolar or transareolar with lateral extension, or via a mammary crease incision. The nipple tissue is sent to pathology as a separate specimen and the nipple must be removed if any carcinoma is identified [",
"      <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/31\">",
"       31",
"      </a>",
"      ]. Resection of the nipple tissue may lead to partial or complete necrosis of the nipple",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      areola in up to 20 percent of cases, and may necessitate subsequent surgical removal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121293963\">",
"    <span class=\"h2\">",
"     Skin flaps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin flaps are raised superiorly to the clavicle, inferiorly to the superior aspect of the rectus sheath, medially to the sternal border, and laterally to the latissimus dorsi muscle edge (",
"    <a class=\"graphic graphic_figure graphicRef80257 \" href=\"UTD.htm?24/5/24657\">",
"     figure 10",
"    </a>",
"    ). Flap thickness should vary with patient body habitus but ideally should be 7 to 8 mm thick. The flaps are raised in the plane deep to the subcutaneous fat and superficial to the breast parenchyma, using scissors, scalpel, or electrocautery (",
"    <a class=\"graphic graphic_figure graphicRef50156 \" href=\"UTD.htm?5/22/5472\">",
"     figure 11",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef61995 \" href=\"UTD.htm?31/9/31903\">",
"     figure 12",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/64-68\">",
"     64-68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121293984\">",
"    <span class=\"h2\">",
"     Dissection from the chest wall",
"    </span>",
"    &nbsp;&mdash;&nbsp;The breast tissue is dissected off the muscle, using cautery to decrease bleeding from the muscle (",
"    <a class=\"graphic graphic_figure graphicRef52804 \" href=\"UTD.htm?8/56/9088\">",
"     figure 13",
"    </a>",
"    ). The pectoralis fascia is routinely removed with the breast tissue. A trial of 247 breast cancer patients undergoing mastectomy randomized patients between removal (n&nbsp;=&nbsp;122) versus preservation (n&nbsp;=&nbsp;125) of the pectoral fascia and reported a trend toward increased risk for chest wall recurrence when the fascia was preserved [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/69\">",
"     69",
"    </a>",
"    ]. There were 18 chest-wall recurrences in the pectoral fascia preservation group versus 10 in the pectoral fascia removal group (hazard ratio&nbsp;1.8, 95% CI&nbsp;0.8-4.0).",
"   </p>",
"   <p>",
"    It is important to remove the breast tissue which lies at the superior-lateral border where the pectoralis major muscle inserts into the humerus. When the lateral border of the breast is reached, the pectoralis muscle is gently retracted medially to expose the axillary content and axillary dissection can be performed if indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20856?source=see_link\">",
"     \"Technique of axillary lymph node dissection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121293977\">",
"    <span class=\"h2\">",
"     Drains",
"    </span>",
"    &nbsp;&mdash;&nbsp;Closed suction drains are placed through separate stab wounds inferior to the main incision and sewn in place (",
"    <a class=\"graphic graphic_figure graphicRef64558 \" href=\"UTD.htm?1/47/1776\">",
"     figure 14",
"    </a>",
"    ). The drains are left in place until the drainage of serous fluid has decreased to approximately 25 to 30 mLs per 24 hour period [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/71\">",
"     71",
"    </a>",
"    ]. If the drains are removed too soon, a seroma can occur, which will require management with aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/72-75\">",
"     72-75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121293998\">",
"    <span class=\"h2\">",
"     Closure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incisions are usually closed in two layers, using absorbable sutures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14332895\">",
"    <span class=\"h3\">",
"     Avoiding dog-ear deformity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The obese or large breasted patient will often have redundant tissue, which can result in an unsightly and uncomfortable &ldquo;dog-ear&rdquo; deformity at the axillary end of the incision. A &ldquo;Y&rdquo; shaped incision can be used to excise excess skin and avoid this deformity (",
"    <a class=\"graphic graphic_figure graphicRef64558 \" href=\"UTD.htm?1/47/1776\">",
"     figure 14",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef63182 \" href=\"UTD.htm?42/38/43631\">",
"     figure 15",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/76\">",
"     76",
"    </a>",
"    ]. Instead of suturing the full length of the wound, the medial one-half to two-thirds of the wound is first sutured using a subcuticular suturing technique. The lateral tip of the incision is then approximated to the midline of the closure, excess skin is removed, and the final wound will be &ldquo;Y&rdquo; or &ldquo;fish-tail&rdquo; shaped with two &ldquo;arms&rdquo; facing towards the lateral side of the wound. In a study of 117 women who underwent mastectomy with a &ldquo;Y&rdquo; shaped incision, the cosmetic outcome was improved and &lt;1 percent developed skin flap necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alternatively, two additional oblique incisions can be added to the traditional transverse elliptical incision at the lateral part of the mastectomy incision site. The resulting lateral triangular flap is advanced medially during the closure of the wound and the redundant skin in the superior and inferior areas is excised.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14332902\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications after mastectomy include seroma, wound infection, skin flap necrosis, chest wall pain, phantom breast syndrome, and arm morbidity. These are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14332910\">",
"    <span class=\"h2\">",
"     Seroma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seroma formation, a collection of serous fluid under the skin flaps, is commonly seen after breast and axillary surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/78-80\">",
"     78-80",
"    </a>",
"    ]. Untreated seroma formation results in delayed wound healing, wound infection, wound dehiscence, flap necrosis, delayed recovery, and poor cosmetic outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/81\">",
"     81",
"    </a>",
"    ]. The pathophysiology of seroma formation is poorly understood, but seroma formation is increased with obesity, extensive surgery, and the use of electrocautery for skin flap dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/82-85\">",
"     82-85",
"    </a>",
"    ]. Seromas are more likely to occur after mastectomy than with breast conservation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/86,87\">",
"     86,87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Drains are effective for seroma prevention in most cases because they obliterate the dead space between the skin flap and the pectoralis muscle [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/88\">",
"     88",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H121293977\">",
"     'Drains'",
"    </a>",
"    above.) Another method of reducing the dead space is by suturing the skin flaps to the underlying muscle, although this may compromise the cosmetic outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/80,88\">",
"     80,88",
"    </a>",
"    ]. Other techniques, such as sealants and sclerotherapy,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    , fibrin glues, patches, and the use of external compression dressings, are not useful [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/89-94\">",
"     89-94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vigorous postoperative shoulder exercises can increase seroma formation. While patients are encouraged to use their arms normally postoperatively for activities of daily living such as brushing their hair or brushing their teeth, formal exercises should be postponed until the drains are removed and any seroma is resolved. A metaanalysis of 6 randomized trials showed that delaying formal exercises significantly decreased seroma formation (odds ratio 0.4; 95% CI 0.2-0.5) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14332917\">",
"    <span class=\"h2\">",
"     Wound infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rates of postoperative wound infection after breast surgery are low because these are clean procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/95-107\">",
"     95-107",
"    </a>",
"    ]. As an example, the wound infection rate after breast surgery was 2.9 percent in a study of 1400 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/108\">",
"     108",
"    </a>",
"    ]. Obesity, smoking, older age, and diabetes mellitus have been identified to be associated with an increased risk of infection after breast surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/109\">",
"     109",
"    </a>",
"    ]. Smoking in particular, increases the risk of wound infection four-fold after breast surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/96\">",
"     96",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36406?source=see_link\">",
"     \"Epidemiology and pathogenesis of and risk factors for surgical site infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A meta-analysis of 2587 surgical breast procedures found a wound infection rate of 3.8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/98\">",
"     98",
"    </a>",
"    ]. Most are staphylococcal infections, caused by skin flora. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most postoperative cellulitis can be treated with oral antibiotics, but nonresponsive or extensive infection requires intravenous antibiotics. A small number of postoperative infections will develop into an abscess requiring drainage by reopening the original surgical incision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1378593387\">",
"    <span class=\"h2\">",
"     Skin flap necrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of skin flap necrosis from MRM or simple mastectomy is estimated at 10 to 18 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/110,111\">",
"     110,111",
"    </a>",
"    ]. Full thickness skin flap necrosis requires surgical debridement and may require skin grafting and result in delays in adjuvant treatment and diminish the cosmetic outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/112\">",
"     112",
"    </a>",
"    ]. Prior radiation treatment, obesity, older age, and a smoking history can increase the rates of flap necrosis. Technical methods of decreasing the risk of skin flap necrosis include minimizing the use of electric cautery method in dissection, maintaining appropriate skin flap thickness, and avoiding tension on closure of the incision.",
"   </p>",
"   <p>",
"    The use of tumescence solution is associated with a high risk of flap necrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/112,113\">",
"     112,113",
"    </a>",
"    ]. Tumescence solution (ie, 1 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    with epinephrine) injected into the subcutaneous tissue obscures the dissection plane. The tumescent mastectomy technique was associated with a fourfold increase in the risk of skin flap necrosis in a series of 100 mastectomies performed using the tumescent technique as compared with 280 mastectomies performed without tumescence [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H510013959\">",
"    <span class=\"h2\">",
"     Pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burning, aching, and tight constriction of the axilla, upper arm, and chest wall, with superimposed lancinations and scar sensitivity are characteristic of postmastectomy pain. In the past, less than 10 percent of patients undergoing mastectomy developed chronic pain [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/114\">",
"     114",
"    </a>",
"    ]; subsequent surveys have reported chronic pain, paresthesias, and phantom sensations in up to one-half of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/115\">",
"     115",
"    </a>",
"    ]. This trend may be related to the radiation and chemotherapy which are often needed in addition to surgery. Although the available data are scant, at least one long-term follow-up study suggests that approximately one-half of cases resolve over time, while the remainder persist long-term [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/116\">",
"     116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors that contribute to the development of postmastectomy pain include axillary dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/117\">",
"     117",
"    </a>",
"    ] and breast reconstruction with implants after mastectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/118\">",
"     118",
"    </a>",
"    ]. Submuscular implant placement can cause injury to the long thoracic, thoracodorsal, lateral-pectoral, and medial-pectoral nerves. Capsule formation around the implant also may entrap the long thoracic and the two pectoral nerves.",
"   </p>",
"   <p>",
"    Evaluation of chest and arm pain after mastectomy should focus upon the nature of the pain and its location, and a neurologic examination to define the areas of sensory loss and hypersensitivity. Pain that is not typical of postmastectomy pain syndrome should prompt evaluation for infection, tumor recurrence, or other causes of chest pain, such as cardiac, pulmonary, or esophageal disease. Progressively worsening pain should prompt suspicion for recurrent disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H510014056\">",
"    <span class=\"h2\">",
"     Phantom breast syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may describe a change in chest wall sensation after mastectomy, sometimes described as \"phantom breast syndrome\" [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/119\">",
"     119",
"    </a>",
"    ]. The sensation of residual breast tissue can persist for years after surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/120\">",
"     120",
"    </a>",
"    ]. The most common complaint is pain, but itching, nipple sensation, erotic sensations, and premenstrual-type breast soreness are also described.",
"   </p>",
"   <p>",
"    Although the cause is unknown, psychologic factors related to mastectomy have been implicated [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/119\">",
"     119",
"    </a>",
"    ]. Patient education before mastectomy, outlining the possible changes in chest wall sensation and the possibility of phantom breast syndrome, may help to relieve patient anxiety if symptoms develop and may even reduce the frequency of this syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H510014144\">",
"    <span class=\"h2\">",
"     Arm morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arm morbidity is common after mastectomy and can include arm swelling, arm pain, arm numbness, arm stiffness, shoulder stiffness, shoulder pain, or nerve injury [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/121\">",
"     121",
"    </a>",
"    ]. Postmastectomy radiation also contributes to arm morbidity and shoulder dysfunction. Complications of axillary surgery are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20856?source=see_link&amp;anchor=H28307087#H28307087\">",
"     \"Technique of axillary lymph node dissection\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After breast cancer surgery, patients should be provided with rehabilitation services as needed and informed about methods to improve shoulder function and reduce the risk of lymphedema [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/122-126\">",
"     122-126",
"    </a>",
"    ]. Prevention and treatment of arm edema are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/52/1866?source=see_link\">",
"     \"Clinical manifestations and diagnosis of lymphedema\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33817?source=see_link\">",
"     \"Prevention and treatment of lymphedema\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H986367415\">",
"    <span class=\"h2\">",
"     Pneumothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumothorax rarely occurs as a complication of breast surgery, usually from inadvertently deep dissection within an intercostal space during a mastectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/18/12586/abstract/109\">",
"     109",
"    </a>",
"    ]. Treatment requires a thoracostomy tube, which is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=see_link\">",
"     \"Placement and management of thoracostomy tubes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H986367423\">",
"    <span class=\"h2\">",
"     Brachial plexopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients can develop brachial plexopathy from a stretch injury caused by malpositioning in the operating room. This can be avoided by careful positioning and the use of padded armboards. (See",
"    <a class=\"local\" href=\"#H986367396\">",
"     'Positioning'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1378593350\">",
"    <span class=\"h1\">",
"     BREAST RECONSTRUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most women undergoing mastectomy are candidates for immediate or delayed breast reconstruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39386?source=see_link\">",
"     \"Breast reconstruction in women with breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1378592681\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preoperative coordination assures the best outcome for breast cancer patients undergoing mastectomy. If postmastectomy radiation is contemplated for patients at high risk for local recurrence, this may affect the choice of mastectomy type, the choice of the reconstructive approach, and optimal timing of the breast reconstruction (immediate versus delayed). (See",
"      <a class=\"local\" href=\"#H10264077\">",
"       'Multidisciplinary coordination for breast cancer patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A mastectomy is indicated for patients who are not candidates for breast conserving therapy, patients who prefer mastectomy, and for prophylactic purposes. (See",
"      <a class=\"local\" href=\"#H1378592045\">",
"       'Selection criteria for mastectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Types of mastectomy include radical mastectomy, modified radical mastectomy, simple mastectomy, skin-sparing mastectomy, and nipple-sparing mastectomy. (See",
"      <a class=\"local\" href=\"#H7005266\">",
"       'Types of mastectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The choice of mastectomy depends on the clinical scenario (see",
"      <a class=\"local\" href=\"#H7006000\">",
"       'Choice of mastectomy'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Radical mastectomy is rarely used unless the tumor invades the pectoral muscle.",
"     </li>",
"     <li>",
"      For patients who are not having immediate reconstruction, a modified radical or simple mastectomy is performed. The difference between a modified radical and a simple mastectomy is that the former includes axillary dissection. With the emergence of sentinel node biopsy, simple mastectomy is performed more commonly.",
"     </li>",
"     <li>",
"      For patients having immediate reconstruction, a skin-sparing mastectomy preserves the skin of the breast and the inframammary fold which provides a superior cosmetic result.",
"     </li>",
"     <li>",
"      For patients having mastectomy for prophylactic purposes, a skin-sparing or nipple-sparing mastectomy will provide the best cosmetic result.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients undergoing a mastectomy should be counseled regarding expected consequences of the procedure such as chest wall numbness, and common risks, such as flap necrosis, hematoma, seroma, and arm morbidity. (See",
"      <a class=\"local\" href=\"#H121294283\">",
"       'Preoperative preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications after mastectomy include seroma, wound infection, skin flap necrosis, chest wall pain, phantom breast syndrome, and arm morbidity. (See",
"      <a class=\"local\" href=\"#H14332902\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most women undergoing mastectomy are candidates for immediate or delayed breast reconstruction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39386?source=see_link\">",
"       \"Breast reconstruction in women with breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/1\">",
"      Roughton MC, Shenaq D, Jaskowiak N, et al. Optimizing delivery of breast conservation therapy: a multidisciplinary approach to oncoplastic surgery. Ann Plast Surg 2012; 69:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/2\">",
"      Chung A, Huynh K, Lawrence C, et al. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol 2012; 19:2600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/3\">",
"      Halsted WS. I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. Ann Surg 1907; 46:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/4\">",
"      Adair F, Berg J, Joubert L, Robbins GF. Long-term followup of breast cancer patients: the 30-year report. Cancer 1974; 33:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/5\">",
"      TURNER-WARWICK RT. The lymphatics of the breast. Br J Surg 1959; 46:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/6\">",
"      Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981; 47:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/7\">",
"      Turner L, Swindell R, Bell WG, et al. Radical versus modified radical mastectomy for breast cancer. Ann R Coll Surg Engl 1981; 63:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/8\">",
"      Maddox WA, Carpenter JT Jr, Laws HL, et al. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg 1983; 198:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/9\">",
"      Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/10\">",
"      Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/11\">",
"      Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987; 71:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/12\">",
"      Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/13\">",
"      Toth BA, Lappert P. Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning. Plast Reconstr Surg 1991; 87:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/14\">",
"      Simmons RM, Adamovich TL. Skin-sparing mastectomy. Surg Clin North Am 2003; 83:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/15\">",
"      Gerber B, Krause A, Reimer T, et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg 2003; 238:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/16\">",
"      Kroll SS, Khoo A, Singletary SE, et al. Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. Plast Reconstr Surg 1999; 104:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/17\">",
"      Rivadeneira DE, Simmons RM, Fish SK, et al. Skin-sparing mastectomy with immediate breast reconstruction: a critical analysis of local recurrence. Cancer J 2000; 6:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/18\">",
"      Medina-Franco H, Vasconez LO, Fix RJ, et al. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg 2002; 235:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/19\">",
"      Carlson GW, Styblo TM, Lyles RH, et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol 2003; 10:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/20\">",
"      Cocquyt VF, Blondeel PN, Depypere HT, et al. Better cosmetic results and comparable quality of life after skin-sparing mastectomy and immediate autologous breast reconstruction compared to breast conservative treatment. Br J Plast Surg 2003; 56:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/21\">",
"      Downes KJ, Glatt BS, Kanchwala SK, et al. Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer 2005; 103:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/22\">",
"      Shen J, Ellenhorn J, Qian D, et al. Skin-sparing mastectomy: a survey based approach to defining standard of care. Am Surg 2008; 74:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/23\">",
"      Warren Peled A, Foster RD, Stover AC, et al. Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol 2012; 19:3402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/24\">",
"      Cheng CJ, Slack FJ. The Duality of OncomiR Addiction in the Maintenance and Treatment of Cancer. Cancer J 2012; 18:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/25\">",
"      Lanitis S, Tekkis PP, Sgourakis G, et al. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg 2010; 251:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/26\">",
"      Newman LA, Kuerer HM, Hunt KK, et al. Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol 1998; 5:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/27\">",
"      Simmons RM, Fish SK, Gayle L, et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies. Ann Surg Oncol 1999; 6:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/28\">",
"      Slavin SA, Schnitt SJ, Duda RB, et al. Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early-stage breast cancer. Plast Reconstr Surg 1998; 102:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/29\">",
"      Foster RD, Esserman LJ, Anthony JP, et al. Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma. Ann Surg Oncol 2002; 9:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/30\">",
"      Dawood S, Merajver SD, Viens P, et al. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 2011; 22:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/31\">",
"      Chung AP, Sacchini V. Nipple-sparing mastectomy: where are we now? Surg Oncol 2008; 17:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/32\">",
"      Crowe JP Jr, Kim JA, Yetman R, et al. Nipple-sparing mastectomy: technique and results of 54 procedures. Arch Surg 2004; 139:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/33\">",
"      Cense HA, Rutgers EJ, Lopes Cardozo M, Van Lanschot JJ. Nipple-sparing mastectomy in breast cancer: a viable option? Eur J Surg Oncol 2001; 27:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/34\">",
"      Wijayanayagam A, Kumar AS, Foster RD, Esserman LJ. Optimizing the total skin-sparing mastectomy. Arch Surg 2008; 143:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/35\">",
"      Laronga C, Kemp B, Johnston D, et al. The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin-sparing mastectomy. Ann Surg Oncol 1999; 6:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/36\">",
"      Voltura AM, Tsangaris TN, Rosson GD, et al. Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteria. Ann Surg Oncol 2008; 15:3396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/37\">",
"      Yueh JH, Houlihan MJ, Slavin SA, et al. Nipple-sparing mastectomy: evaluation of patient satisfaction, aesthetic results, and sensation. Ann Plast Surg 2009; 62:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/38\">",
"      Blechman KM, Karp NS, Levovitz C, et al. The lateral inframammary fold incision for nipple-sparing mastectomy: outcomes from over 50 immediate implant-based breast reconstructions. Breast J 2013; 19:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/39\">",
"      Spear SL, Hannan CM, Willey SC, Cocilovo C. Nipple-sparing mastectomy. Plast Reconstr Surg 2009; 123:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/40\">",
"      Stolier A, Stone JC, Moroz K, et al. A comparison of clinical and pathologic assessments for the prediction of occult nipple involvement in nipple-sparing mastectomies. Ann Surg Oncol 2013; 20:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/41\">",
"      de Alcantara Filho P, Capko D, Barry JM, et al. Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol 2011; 18:3117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/42\">",
"      Gerber B, Krause A, Dieterich M, et al. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg 2009; 249:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/43\">",
"      Steen ST, Chung AP, Han SH, et al. Predicting nipple-areolar involvement using preoperative breast MRI and primary tumor characteristics. Ann Surg Oncol 2013; 20:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/44\">",
"      Leaper DJ, Melling AG. Antibiotic prophylaxis in clean surgery: clean non-implant wounds. J Chemother 2001; 13 Spec No 1:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/45\">",
"      Gagliardi AR, Fenech D, Eskicioglu C, et al. Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature. Can J Surg 2009; 52:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/46\">",
"      Throckmorton AD, Boughey JC, Boostrom SY, et al. Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol 2009; 16:2464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/47\">",
"      Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/48\">",
"      Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/49\">",
"      Braxton CC, Gerstenberger PA, Cox GG. Improving antibiotic stewardship: order set implementation to improve prophylactic antimicrobial prescribing in the outpatient surgical setting. J Ambul Care Manage 2010; 33:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/50\">",
"      Tejirian T, DiFronzo LA, Haigh PI. Antibiotic prophylaxis for preventing wound infection after breast surgery: a systematic review and metaanalysis. J Am Coll Surg 2006; 203:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/51\">",
"      Andtbacka RH, Babiera G, Singletary SE, et al. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 2006; 243:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/52\">",
"      Friis E, H&oslash;rby J, S&oslash;rensen LT, et al. Thromboembolic prophylaxis as a risk factor for postoperative complications after breast cancer surgery. World J Surg 2004; 28:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/53\">",
"      Coveney E, Weltz CR, Greengrass R, et al. Use of paravertebral block anesthesia in the surgical management of breast cancer: experience in 156 cases. Ann Surg 1998; 227:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/54\">",
"      Thavaneswaran P, Rudkin GE, Cooter RD, et al. Brief reports: paravertebral block for anesthesia: a systematic review. Anesth Analg 2010; 110:1740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/55\">",
"      Pusch F, Freitag H, Weinstabl C, et al. Single-injection paravertebral block compared to general anaesthesia in breast surgery. Acta Anaesthesiol Scand 1999; 43:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/56\">",
"      Cooter RD, Rudkin GE, Gardiner SE. Day case breast augmentation under paravertebral blockade: a prospective study of 100 consecutive patients. Aesthetic Plast Surg 2007; 31:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/57\">",
"      Naja ZM, Naccache N, Ziade F, et al. Multilevel nerve stimulator-guided paravertebral block as a sole anesthetic technique for breast cancer surgery in morbidly obese patients. J Anesth 2011; 25:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/58\">",
"      Tahiri Y, Tran de QH, Bouteaud J, et al. General anaesthesia versus thoracic paravertebral block for breast surgery: a meta-analysis. J Plast Reconstr Aesthet Surg 2011; 64:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/59\">",
"      Iohom G, Abdalla H, O'Brien J, et al. The associations between severity of early postoperative pain, chronic postsurgical pain and plasma concentration of stable nitric oxide products after breast surgery. Anesth Analg 2006; 103:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/60\">",
"      Kairaluoma PM, Bachmann MS, Rosenberg PH, Pere PJ. Preincisional paravertebral block reduces the prevalence of chronic pain after breast surgery. Anesth Analg 2006; 103:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/61\">",
"      Exadaktylos AK, Buggy DJ, Moriarty DC, et al. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006; 105:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/62\">",
"      Sabel MS, Degnim A, Wilkins EG, et al. Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer. Am J Surg 2004; 187:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/63\">",
"      Cocilovo C, Boolbol SK, Valdes E, Feldman S. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience. Am J Surg 2006; 192:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/64\">",
"      Manouras A, Markogiannakis H, Genetzakis M, et al. Modified radical mastectomy with axillary dissection using the electrothermal bipolar vessel sealing system. Arch Surg 2008; 143:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/65\">",
"      Kontos M, Kothari A, Hamed H. Effect of harmonic scalpel on seroma formation following surgery for breast cancer: a prospective randomized study. J BUON 2008; 13:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/66\">",
"      Bandi G, Wen CC, Wilkinson EA, et al. Comparison of blade temperature dynamics after activation of Harmonic Ace scalpel and the Ultracision Harmonic Scalpel LCS-K5. J Endourol 2008; 22:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/67\">",
"      Sanguinetti A, Docimo G, Ragusa M, et al. Ultrasound scissors versus electrocautery in axillary dissection: our experience. G Chir 2010; 31:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/68\">",
"      Galatius H, Okholm M, Hoffmann J. Mastectomy using ultrasonic dissection: effect on seroma formation. Breast 2003; 12:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/69\">",
"      Dalberg K, Krawiec K, Sandelin K. Eleven-year follow-up of a randomized study of pectoral fascia preservation after mastectomy for early breast cancer. World J Surg 2010; 34:2539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/70\">",
"      Roses DF, Harris MN, Gumport SL. Total mastectomy with axillary dissection. A modified radical mastectomy. Am J Surg 1977; 134:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/71\">",
"      Shamley DR, Barker K, Simonite V, Beardshaw A. Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat 2005; 90:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/72\">",
"      Barton A, Blitz M, Callahan D, et al. Early removal of postmastectomy drains is not beneficial: results from a halted randomized controlled trial. Am J Surg 2006; 191:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/73\">",
"      Singhal V, Singh J, Bansal A, et al. Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer- a prospective randomized clinical trial[ISRCTN24484328]. BMC Cancer 2005; 5:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/74\">",
"      Dalberg K, Johansson H, Signomklao T, et al. A randomised study of axillary drainage and pectoral fascia preservation after mastectomy for breast cancer. Eur J Surg Oncol 2004; 30:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/75\">",
"      Kopelman D, Klemm O, Bahous H, et al. Postoperative suction drainage of the axilla: for how long? Prospective randomised trial. Eur J Surg 1999; 165:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/76\">",
"      Farrar WB, Fanning WJ. Eliminating the dog-ear in modified radical mastectomy. Am J Surg 1988; 156:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/77\">",
"      Szynglarewicz B, Matkowski R, Kasprzak P, et al. Mastectomy approach with Y-shaped incision: a technique designed for women with obesity. Int J Gynecol Cancer 2009; 19:1454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/78\">",
"      Anand R, Skinner R, Dennison G, Pain JA. A prospective randomised trial of two treatments for wound seroma after breast surgery. Eur J Surg Oncol 2002; 28:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/79\">",
"      Boostrom SY, Throckmorton AD, Boughey JC, et al. Incidence of clinically significant seroma after breast and axillary surgery. J Am Coll Surg 2009; 208:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/80\">",
"      van Bemmel AJ, van de Velde CJ, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol 2011; 37:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/81\">",
"      Agrawal A, Ayantunde AA, Cheung KL. Concepts of seroma formation and prevention in breast cancer surgery. ANZ J Surg 2006; 76:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/82\">",
"      Porter KA, O'Connor S, Rimm E, Lopez M. Electrocautery as a factor in seroma formation following mastectomy. Am J Surg 1998; 176:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/83\">",
"      Pogson CJ, Adwani A, Ebbs SR. Seroma following breast cancer surgery. Eur J Surg Oncol 2003; 29:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/84\">",
"      Bonnema J, Ligtenstein DA, Wiggers T, van Geel AN. The composition of serous fluid after axillary dissection. Eur J Surg 1999; 165:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/85\">",
"      Petrek JA, Peters MM, Nori S, et al. Axillary lymphadenectomy. A prospective, randomized trial of 13 factors influencing drainage, including early or delayed arm mobilization. Arch Surg 1990; 125:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/86\">",
"      Gonzalez EA, Saltzstein EC, Riedner CS, Nelson BK. Seroma formation following breast cancer surgery. Breast J 2003; 9:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/87\">",
"      Hashemi E, Kaviani A, Najafi M, et al. Seroma formation after surgery for breast cancer. World J Surg Oncol 2004; 2:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/88\">",
"      Coveney EC, O'Dwyer PJ, Geraghty JG, O'Higgins NJ. Effect of closing dead space on seroma formation after mastectomy--a prospective randomized clinical trial. Eur J Surg Oncol 1993; 19:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/89\">",
"      Chen CY, Hoe AL, Wong CY. The effect of a pressure garment on post-surgical drainage and seroma formation in breast cancer patients. Singapore Med J 1998; 39:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/90\">",
"      Sitzmann JV, Dufresne C, Zuidema GD. The use of sclerotherapy for treatment of postmastectomy wound seromas. Surgery 1983; 93:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/91\">",
"      Nichter LS, Morgan RF, Dufresne CR, et al. Rapid management of persistent seromas by sclerotherapy. Ann Plast Surg 1983; 11:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/92\">",
"      Jain PK, Sowdi R, Anderson AD, MacFie J. Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. Br J Surg 2004; 91:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/93\">",
"      Johnson L, Cusick TE, Helmer SD, Osland JS. Influence of fibrin glue on seroma formation after breast surgery. Am J Surg 2005; 189:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/94\">",
"      O'Hea BJ, Ho MN, Petrek JA. External compression dressing versus standard dressing after axillary lymphadenectomy. Am J Surg 1999; 177:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/95\">",
"      Tran CL, Langer S, Broderick-Villa G, DiFronzo LA. Does reoperation predispose to postoperative wound infection in women undergoing operation for breast cancer? Am Surg 2003; 69:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/96\">",
"      S&oslash;rensen LT, H&oslash;rby J, Friis E, et al. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2002; 28:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/97\">",
"      Wagman LD, Tegtmeier B, Beatty JD, et al. A prospective, randomized double-blind study of the use of antibiotics at the time of mastectomy. Surg Gynecol Obstet 1990; 170:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/98\">",
"      Platt R, Zucker JR, Zaleznik DF, et al. Perioperative antibiotic prophylaxis and wound infection following breast surgery. J Antimicrob Chemother 1993; 31 Suppl B:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/99\">",
"      Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med 1990; 322:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/100\">",
"      Chen J, Gutkin Z, Bawnik J. Postoperative infections in breast surgery. J Hosp Infect 1991; 17:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/101\">",
"      Vinton AL, Traverso LW, Jolly PC. Wound complications after modified radical mastectomy compared with tylectomy with axillary lymph node dissection. Am J Surg 1991; 161:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/102\">",
"      Thomas R, Alvino P, Cortino GR, et al. Long-acting versus short-acting cephalosporins for preoperative prophylaxis in breast surgery: A randomized double-blind trial involving 1,766 patients. Chemotherapy 1999; 45:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/103\">",
"      Lipshy KA, Neifeld JP, Boyle RM, et al. Complications of mastectomy and their relationship to biopsy technique. Ann Surg Oncol 1996; 3:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/104\">",
"      Bertin ML, Crowe J, Gordon SM. Determinants of surgical site infection after breast surgery. Am J Infect Control 1998; 26:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/105\">",
"      Nieto A, Lozano M, Moro MT, et al. Determinants of wound infections after surgery for breast cancer. Zentralbl Gynakol 2002; 124:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/106\">",
"      Witt A, Yavuz D, Walchetseder C, et al. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet Gynecol 2003; 101:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/107\">",
"      Chatzidaki P, Mellos C, Briese V, Mylonas I. Perioperative complications of breast cancer surgery in elderly women (&ge;80 years). Ann Surg Oncol 2011; 18:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/108\">",
"      Sanguinetti A, Rosato L, Cirocchi R, et al. [Antibiotic prophylaxis in breast surgery. Preliminary resuls of a multicenter randomized study on 1400 cases]. Ann Ital Chir 2009; 80:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/109\">",
"      Vitug AF, Newman LA. Complications in breast surgery. Surg Clin North Am 2007; 87:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/110\">",
"      Carlson GW, Bostwick J 3rd, Styblo TM, et al. Skin-sparing mastectomy. Oncologic and reconstructive considerations. Ann Surg 1997; 225:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/111\">",
"      Rao R, Saint-Cyr M, Ma AM, et al. Prediction of post-operative necrosis after mastectomy: a pilot study utilizing optical diffusion imaging spectroscopy. World J Surg Oncol 2009; 7:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/112\">",
"      Chun YS, Verma K, Rosen H, et al. Use of tumescent mastectomy technique as a risk factor for native breast skin flap necrosis following immediate breast reconstruction. Am J Surg 2011; 201:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/113\">",
"      Abbott AM, Miller BT, Tuttle TM. Outcomes after tumescence technique versus electrocautery mastectomy. Ann Surg Oncol 2012; 19:2607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/114\">",
"      Elliott K, Foley KM. Neurologic pain syndromes in patients with cancer. Crit Care Clin 1990; 6:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/115\">",
"      Tasmuth T, von Smitten K, Hietanen P, et al. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol 1995; 6:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/116\">",
"      Macdonald L, Bruce J, Scott NW, et al. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 2005; 92:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/117\">",
"      Maunsell E, Brisson J, Desch&ecirc;nes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993; 36:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/118\">",
"      Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain 1996; 66:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/119\">",
"      Jamison K, Wellisch DK, Katz RL, Pasnau RO. Phantom breast syndrome. Arch Surg 1979; 114:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/120\">",
"      Kr&oslash;ner K, Knudsen UB, Lundby L, Hvid H. Long-term phantom breast syndrome after mastectomy. Clin J Pain 1992; 8:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/121\">",
"      Arndt V, Merx H, Stegmaier C, et al. Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 2005; 23:4945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/122\">",
"      Sclafani LM, Baron RH. Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction. Cancer J 2008; 14:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/123\">",
"      Cave J, Jones A. Physiotherapy improves shoulder function after treatment in women with early breast cancer. Cancer Treat Rev 2006; 32:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/124\">",
"      de Rezende LF, Franco RL, de Rezende MF, et al. Two exercise schemes in postoperative breast cancer: comparison of effects on shoulder movement and lymphatic disturbance. Tumori 2006; 92:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/125\">",
"      Beurskens CH, van Uden CJ, Strobbe LJ, et al. The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer 2007; 7:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/18/12586/abstract/126\">",
"      Torres Lacomba M, Yuste S&aacute;nchez MJ, Zapico Go&ntilde;i A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 2010; 340:b5396.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14981 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-190.81.197.98-C735D61C62-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12586=[""].join("\n");
var outline_f12_18_12586=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1378592681\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14332858\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10264077\">",
"      MULTIDISCIPLINARY COORDINATION FOR BREAST CANCER PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1378592045\">",
"      SELECTION CRITERIA FOR MASTECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H121293930\">",
"      Breast conservation is contraindicated or unsuccessful",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H121293916\">",
"      Patient choice",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H121293923\">",
"      Prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7005266\">",
"      TYPES OF MASTECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7005293\">",
"      Radical mastectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7005300\">",
"      Modified radical mastectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7005307\">",
"      Simple mastectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7005314\">",
"      Skin-sparing mastectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7005321\">",
"      Nipple-sparing mastectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7006000\">",
"      CHOICE OF MASTECTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30366169\">",
"      SURGICAL ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H121294283\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30366296\">",
"      Mark the site and side",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30366288\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30366280\">",
"      Deep venous thrombosis prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30366515\">",
"      ANESTHETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14332888\">",
"      SURGICAL TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H986367396\">",
"      Positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H121294083\">",
"      Axillary staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H121293956\">",
"      Incision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H121293963\">",
"      Skin flaps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H121293984\">",
"      Dissection from the chest wall",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H121293977\">",
"      Drains",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H121293998\">",
"      Closure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14332895\">",
"      - Avoiding dog-ear deformity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14332902\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14332910\">",
"      Seroma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14332917\">",
"      Wound infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1378593387\">",
"      Skin flap necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H510013959\">",
"      Pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H510014056\">",
"      Phantom breast syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H510014144\">",
"      Arm morbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H986367415\">",
"      Pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H986367423\">",
"      Brachial plexopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1378593350\">",
"      BREAST RECONSTRUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1378592681\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/14981\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/14981|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/36/8772\" title=\"figure 1\">",
"      Incisions for skin sparing mastectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/27/43447\" title=\"figure 2\">",
"      Anatomy of the chest wall and axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/5/17493\" title=\"figure 3\">",
"      Superficial anatomy of the axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/5/18520\" title=\"figure 4\">",
"      Structures of the axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/21/5460\" title=\"figure 5\">",
"      Incisions for mastectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/53/25430\" title=\"figure 6\">",
"      Mastectomy incisions for central breast tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/49/14102\" title=\"figure 7\">",
"      Mastectomy incisions for inner quadrant tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/28/11714\" title=\"figure 8\">",
"      Mastectomy incisions for lower outer quadrant tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/6/17510\" title=\"figure 9\">",
"      Mastectomy incisions for upper outer quadrant tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/5/24657\" title=\"figure 10\">",
"      Limits of the dissection for mastectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/22/5472\" title=\"figure 11\">",
"      Mastectomy skin flap development",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/9/31903\" title=\"figure 12\">",
"      Skin sparing mastectomy flap development",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/56/9088\" title=\"figure 13\">",
"      Mobilization of the breast off the chest wall for mastectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/47/1776\" title=\"figure 14\">",
"      Mastectomy closure and drain placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/38/43631\" title=\"figure 15\">",
"      Prevention of dog ear deformity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/14981|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/46/23275\" title=\"table 1\">",
"      Timing of surgical prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/54/35693\" title=\"table 2\">",
"      Perioperative VTE prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17207?source=related_link\">",
"      Breast cancer during pregnancy and lactation: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/42/31402?source=related_link\">",
"      Breast conserving therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/29/39386?source=related_link\">",
"      Breast reconstruction in women with breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/52/1866?source=related_link\">",
"      Clinical manifestations and diagnosis of lymphedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/36/24138?source=related_link\">",
"      Diagnostic evaluation of women with suspected breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36406?source=related_link\">",
"      Epidemiology and pathogenesis of and risk factors for surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=related_link\">",
"      Inflammatory breast cancer: Clinical features and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17418?source=related_link\">",
"      Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/40/35466?source=related_link\">",
"      Neoadjuvant therapy for breast cancer: Rationale, pretreatment evaluation, and therapeutic options",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/46/19177?source=related_link\">",
"      Overview of the treatment of newly diagnosed, non-metastatic breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18042?source=related_link\">",
"      Peripheral nerve block: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=related_link\">",
"      Placement and management of thoracostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/3/41017?source=related_link\">",
"      Postmastectomy chest wall irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33817?source=related_link\">",
"      Prevention and treatment of lymphedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/26/35242?source=related_link\">",
"      Second malignancies after treatment of classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20296?source=related_link\">",
"      Sentinel lymph node biopsy in breast cancer: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/47/36602?source=related_link\">",
"      Sentinel lymph node dissection for breast cancer: Indications and outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/23/20856?source=related_link\">",
"      Technique of axillary lymph node dissection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_18_12587="Hormones inhibited by somatostatin";
var content_f12_18_12587=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F67174&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F67174&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hormones inhibited by somatostatin",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Acetylcholine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arginine vasopressin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cholecystokinin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidermal growth hormone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucagon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucose-dependent insulinotropic peptide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Growth hormone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motilin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurotensin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancreatic polypeptide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Secretin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serotonin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Substance P",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thyrotropin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vasoactive intestinal polypeptide",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12587=[""].join("\n");
var outline_f12_18_12587=null;
var title_f12_18_12588="Differential diagnosis of primary encephalocele";
var content_f12_18_12588=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68011&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68011&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of primary (congenital) encephalocele",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of encephalocele",
"       </td>",
"       <td class=\"subtitle1\">",
"        Differential diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        <strong>",
"         Occipital encephalocele",
"        </strong>",
"       </td>",
"       <td>",
"        Midline dermoid cysts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemangiomas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular malformations of the scalp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cystic hygroma",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        <strong>",
"         Cranial vault",
"        </strong>",
"       </td>",
"       <td>",
"        Congenital parietal foramina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scalp defects (aplasia cutis congenita)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dermoid cysts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemangiomas",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         Frontoethmoidal and basal",
"        </strong>",
"       </td>",
"       <td>",
"        Dermoid cysts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemangiomas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sinus pericranii",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"4\">",
"        Basal",
"       </td>",
"       <td>",
"        Inflammatory nasal polyps",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atretic cephaloceles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucocele of the paranasal sinuses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neoplasms of the nasal cavity and pharynx",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"3\">",
"        Spheno-orbital or frontosphenoidal",
"       </td>",
"       <td>",
"        Orbital teratoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unilateral agenesis of the sphenoid and orbital plate (eg, in neurofibromatosis I)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital cystic eye",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Towfighi J. Cephaloceles. MedLink Neurology 1995 (updated 12/2010). Available at:",
"     <a href=\"file://www.medlink.com/medlinkcontent.asp\" target=\"_blank\">",
"      file://www.medlink.com/medlinkcontent.asp",
"     </a>",
"     (accessed 11/15/11).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12588=[""].join("\n");
var outline_f12_18_12588=null;
var title_f12_18_12589="Strep bovis susceptibilities II";
var content_f12_18_12589=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52108&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Representative susceptibilities of Streptococcus bovis to antibiotics",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Antimicrobial",
"       </td>",
"       <td class=\"subtitle1\">",
"        MIC range, &micro;g/mL*",
"       </td>",
"       <td class=\"subtitle1\">",
"        MIC50 range, &micro;g/mL",
"        <span class=\"small\">",
"         &bull;",
"        </span>",
"       </td>",
"       <td class=\"subtitle1\">",
"        MIC90 range, &micro;g/mL",
"        <span class=\"small\">",
"         &bull;",
"        </span>",
"       </td>",
"       <td class=\"subtitle1\">",
"        References",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meropenem",
"       </td>",
"       <td>",
"        0.015-0.12",
"       </td>",
"       <td>",
"        0.12",
"       </td>",
"       <td>",
"        0.12",
"       </td>",
"       <td>",
"        Schouten, 1997; Hoogkamp-Korstanje, 2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vancomycin",
"       </td>",
"       <td>",
"        0.13-2",
"       </td>",
"       <td>",
"        0.25-0.5",
"       </td>",
"       <td>",
"        0.5-1",
"       </td>",
"       <td>",
"        Eggers, 1992; Mouton, 1997; Fass, 1991; Schouten, 1997; Kerwala, 2001; Hoogkamp-Korstanje, 2000; Streit, 2005; Moet, 2007",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythromycin",
"       </td>",
"       <td>",
"        &le;0.008-&gt;256",
"       </td>",
"       <td>",
"        0.03-&gt;256",
"       </td>",
"       <td>",
"        1-&gt;32",
"       </td>",
"       <td>",
"        Pfaller, 1997; Mouton, 1997; Schouten, 1997; Fass, 1993; Hoogkamp-Korstanje, 2000; Streit, 2005; Moet, 2007",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clarithromycin",
"       </td>",
"       <td>",
"        &le;0.015-&gt;32",
"       </td>",
"       <td>",
"        &lt;0.125",
"       </td>",
"       <td>",
"        0.5-&gt;32",
"       </td>",
"       <td>",
"        Mouton, 1997; Fass, 1993; Hoogkamp-Korstanje, 2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clindamycin",
"       </td>",
"       <td>",
"        &le;0.008-&gt;16",
"       </td>",
"       <td>",
"        0.03-0.125",
"       </td>",
"       <td>",
"        &gt;16",
"       </td>",
"       <td>",
"        Mouton, 1997; Streit, 2005; Moet, 2007",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinupristin-dalfopristin",
"       </td>",
"       <td>",
"        0.015-16",
"       </td>",
"       <td>",
"        0.5-2",
"       </td>",
"       <td>",
"        1-16",
"       </td>",
"       <td>",
"        Mouton, 1997; Fass, 1991; Schouten, 1997; Barrett, 1996; Streit, 2005",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rifampin",
"       </td>",
"       <td>",
"        &le;0.015-0.25",
"       </td>",
"       <td>",
"        0.125",
"       </td>",
"       <td>",
"        0.12-0.25",
"       </td>",
"       <td>",
"        Fass, 1991; Schouten, 1997",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tetracycline",
"       </td>",
"       <td>",
"        0.25-&ge;32",
"       </td>",
"       <td>",
"        &gt;8",
"       </td>",
"       <td>",
"        &gt;8-&ge;32",
"       </td>",
"       <td>",
"        Kerwala, 2001; Streit, 2005; Moet, 2007",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ciprofloxacin",
"       </td>",
"       <td>",
"        0.25-&ge;32",
"       </td>",
"       <td>",
"        1-4",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        Eggers, 1992; Fass, 1991; Fass, 1993; Etienne, 1988; Schouten, 1997; Neu, 1994; Kerwala, 2001; Hoogkamp-Korstanje, 2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Levofloxacin",
"       </td>",
"       <td>",
"        0.5-&ge;32",
"       </td>",
"       <td>",
"        1-4",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        Kerwala, 2001; Hoogkamp-Korstanje, 2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moxifloxacin",
"       </td>",
"       <td>",
"        0.06-0.5",
"       </td>",
"       <td>",
"        0.12",
"       </td>",
"       <td>",
"        0.25",
"       </td>",
"       <td>",
"        Hoogkamp-Korstanje, 2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Daptomycin",
"       </td>",
"       <td>",
"        0.03-0.25",
"       </td>",
"       <td>",
"        0.03",
"       </td>",
"       <td>",
"        0.06",
"       </td>",
"       <td>",
"        Streit, 2005",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Linezolid",
"       </td>",
"       <td>",
"        0.5-2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        Streit, 2005; Moet, 2007",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tigecycline",
"       </td>",
"       <td>",
"        &le;0.06",
"       </td>",
"       <td>",
"        &le;0.06",
"       </td>",
"       <td>",
"        &le;0.06",
"       </td>",
"       <td>",
"        Moet, 2007",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Minimum and maximum values of minimal inhibitory concentration (MIC) ranges given.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Range of concentrations inhibiting 50 percent (MIC50) and 90 percent (MIC90) of isolates.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12589=[""].join("\n");
var outline_f12_18_12589=null;
var title_f12_18_12590="LY290181 and vascular function";
var content_f12_18_12590=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F73671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F73671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Protein kinase C inhibition protects against hyperglycemia-induced vascular dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 445px; height: 323px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Effect of the PKC inhibitor LY290181 on vascular dysfunction in skin chamber granulation tissue induced by elevated glucose levels in nondiabetic rats. Skin chamber granulation tissue was treated with either 5 or 30 mmol/L of glucose alone or 30 mmol/L of glucose plus 20 to 50 &micro;mol/L of LY290181 twice daily for seven days. Exposure to the high glucose solution increased both blood flow and vascular permeability; these effects were prevented by LY290181.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12590=[""].join("\n");
var outline_f12_18_12590=null;
var title_f12_18_12591="Stroke mortality related to BP and age";
var content_f12_18_12591=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F66793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F66793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Stroke mortality related to blood pressure and age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 390px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stroke mortality rate, pictured on a log scale with 95 percent confidence intervals, in each decade of age in relation to the estimated usual systolic and diastolic blood pressure at the start of that decade. Stroke mortality increases with both higher pressures and older ages. For diastolic pressure, each age-specific regression line ignores the left-hand point (ie, at slightly less than 75 mmHg), for which the risk lies significantly above the fitted regression line (as indicated by the broken line below 75 mmHg).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Prospective Studies Collaboration, Lancet 2002; 360:1903.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_18_12591=[""].join("\n");
var outline_f12_18_12591=null;
